<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xml:lang="EN" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?origin publisher?><?properties no_embargo?><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pflugers Arch</journal-id><journal-title>Pflugers Archiv </journal-title><issn pub-type="ppub">0031-6768</issn><issn pub-type="epub">1432-2013</issn><publisher><publisher-name>Springer-Verlag</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">671</article-id><article-id pub-id-type="doi">10.1007/s00424-009-0671-1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Cardiovascular Physiology</subject></subj-group></article-categories><title-group><article-title>Empirical correlation of triggered activity and spatial and temporal re-entrant substrates with arrhythmogenicity in a murine model for Jervell and Lange-Nielsen syndrome</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Hothi</surname><given-names>Sandeep S.</given-names></name><address><email>ssh26@cam.ac.uk</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Thomas</surname><given-names>Glyn</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Killeen</surname><given-names>Matthew J.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Grace</surname><given-names>Andrew A.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Huang</surname><given-names>Christopher L.-H.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label>Physiological Laboratory, Department of Physiology, Development and Neuroscience, University of Cambridge, Downing Street, Cambridge, CB2 3EG UK </aff><aff id="Aff2"><label>2</label>Section of Cardiovascular Biology, Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QW UK </aff><aff id="Aff3"><label>3</label>Cardiovascular Research Centre, Massachusetts General Hospital, 149 13th Street, Charlestown, MA 02129 USA </aff><aff id="Aff4"><label>4</label>Harvard Medical School, 25 Shattuck Street, Boston, MA 02115 USA </aff></contrib-group><pub-date pub-type="epub"><day>9</day><month>5</month><year>2009</year></pub-date><pub-date pub-type="ppub"><month>9</month><year>2009</year></pub-date><volume>458</volume><issue>5</issue><fpage>819</fpage><lpage>835</lpage><history><date date-type="received"><day>5</day><month>4</month><year>2009</year></date><date date-type="accepted"><day>7</day><month>4</month><year>2009</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2009</copyright-statement></permissions><abstract xml:lang="EN"><p><italic>KCNE1</italic> encodes the &#x003b2;-subunit of the slow component of the delayed rectifier K<sup>+</sup> current. The Jervell and Lange-Nielsen syndrome is characterized by sensorineural deafness, prolonged QT intervals, and ventricular arrhythmogenicity. Loss-of-function mutations in <italic>KCNE1</italic> are implicated in the JLN2 subtype. We recorded left ventricular epicardial and endocardial monophasic action potentials (MAPs) in intact, Langendorff-perfused mouse hearts. <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> but not wild-type (WT) hearts showed not only triggered activity and <italic>spontaneous</italic> ventricular tachycardia (VT), but also VT <italic>provoked</italic> by programmed electrical stimulation. The presence or absence of VT was related to the following set of criteria for re-entrant excitation for the first time in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts: Quantification of APD<sub>90</sub>, the MAP duration at 90% repolarization, demonstrated alterations in (1) the difference, &#x02206;APD<sub>90</sub>, between endocardial and epicardial APD<sub>90</sub> and (2) critical intervals for local re-excitation, given by differences between APD<sub>90</sub> and ventricular effective refractory period, reflecting <italic>spatial</italic> re-entrant substrate. <italic>Temporal</italic> re-entrant substrate was reflected in (3) increased APD<sub>90</sub> alternans, through a range of pacing rates, and (4) steeper epicardial and endocardial APD<sub>90</sub> restitution curves determined with a dynamic pacing protocol. (5) Nicorandil (20&#x000a0;&#x000b5;M) rescued spontaneous and provoked arrhythmogenic phenomena in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts. WTs remained nonarrhythmogenic. Nicorandil correspondingly restored parameters representing re-entrant criteria in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts toward values found in untreated WTs. It shifted such values in WT hearts in similar directions. Together, these findings directly implicate triggered electrical activity and spatial and temporal re-entrant mechanisms in the arrhythmogenesis observed in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts.</p></abstract><kwd-group><title>Keywords</title><kwd>Mice</kwd><kwd>Action potential duration</kwd><kwd>Ventricular arrhythmogenesis</kwd><kwd>Re-entry</kwd></kwd-group><custom-meta-wrap><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag 2009</meta-value></custom-meta></custom-meta-wrap></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p>Ventricular tachycardia (VT) is an important cause of morbidity and mortality accounting for 80% of the annual 50,000&#x02013;70,000 cases of sudden cardiac death (SCD) in the UK [<xref ref-type="bibr" rid="CR36">36</xref>] and over 300,000&#x02013;400,000 cases in the USA [<xref ref-type="bibr" rid="CR77">77</xref>]. A subset of these deaths is caused by an inherited predisposition to VT of which congenital long QT syndrome (LQTS) forms an important genetically transmitted category with a prevalence recently estimated at one in 2,500 live births [<xref ref-type="bibr" rid="CR8">8</xref>].</p><p>LQTS patients have been classified according to their mode of transmission into the autosomal recessive Jervell and Lange-Nielsen (JLN) syndrome [<xref ref-type="bibr" rid="CR20">20</xref>] or the autosomal dominant Romano&#x02013;Ward (RW) syndrome [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR71">71</xref>]. Jervell and Lange-Nielsen in 1957 provided the first report of LQTS in their description of a Norwegian family with four out of six children having deaf-mutism, prolonged electrocardiographic QT intervals, syncopal episodes, and sudden death. JLN and RW syndromes are thus additionally differentiated phenotypically by the congenital bilateral sensorineural deafness that afflicts patients with JLN syndrome but not RW syndrome [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR71">71</xref>]. Since the first report of LQTS, a wide range of LQTS subtypes have been discovered (reviewed by [<xref ref-type="bibr" rid="CR6">6</xref>]). All of these affect ion channels or proteins that interact with ion channels, predisposing patients to potentially lethal ventricular arrhythmias, syncope, SCD, characteristic prolonged electrocardiographic QT intervals, and in some cases, T wave abnormalities [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]. Such conditions provide opportunities to study mechanisms of arrhythmia resulting from defined genetic abnormalities.</p><p>The <italic>KCNE1</italic> gene encodes a 129-amino acid protein, minK, an accessory &#x003b2;-subunit that, together with KvLQT1 &#x003b1;-subunits (encoded by the <italic>KCNQ1</italic> gene), form the slow component [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR49">49</xref>] of the delayed rectifier K<sup>+</sup> current in cardiac myocytes [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. Autosomal dominant heterozygous mutations in the <italic>KCNE1</italic> gene may result in the long QT 5 syndrome [<xref ref-type="bibr" rid="CR62">62</xref>]. More marked reductions in <italic>I</italic><sub>Ks</sub> resulting from homozygous or compound heterozygous mutations in <italic>KCNQ1</italic> or <italic>KCNE1</italic> can give rise to the characteristic JLN syndrome [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR67">67</xref>]. JLN syndrome has, therefore, been classified into JLN1 and JLN2, distinguishing between associated mutations in <italic>KCNQ1</italic> or <italic>KCNE1</italic>, respectively [<xref ref-type="bibr" rid="CR6">6</xref>]. Loss-of-function mutations in <italic>KCNE1</italic>, which may give rise to LQT5 or JLN2 are thus associated with reduced K<sup>+</sup> currents and compromised repolarization reserve.</p><p>Further experimental studies exploring for mechanisms of arrhythmogenesis and potential therapeutic approaches in JLN syndrome, with due attention to the gene in which the primary genetic abnormality resides, are thus of significant interest. Such gene-specific investigations of JLN syndrome at the experimental level are warranted, firstly, in view of the fact that the JLN1 and JLN2 variants, both particularly severe forms of LQTS [<xref ref-type="bibr" rid="CR56">56</xref>], while clinically similar [<xref ref-type="bibr" rid="CR67">67</xref>], have mutations in distinct genes. Secondly, JLN syndrome is rare, with an estimated incidence of 1.6 to six cases per million [<xref ref-type="bibr" rid="CR10">10</xref>]. Thirdly, besides involving &#x003b2;-subunits rather than &#x003b1;-subunits of the channels concerned, <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> mutations accounted for 9.5% of patients with JLN syndrome that could be successfully genotyped in a recent clinical review [<xref ref-type="bibr" rid="CR56">56</xref>]. There is, therefore, limited knowledge about the mechanisms involved and possible therapeutic approaches in both JLN syndrome and JLN2 in particular. Finally, there are potential therapeutic implications for studying JLN syndrome according to the underlying genetic abnormality in view of a range of treatment options for LQTS, including pharmacological approaches such as &#x003b2;-blockers, as well as pacemakers, left cervicothoracic sympathectomy, and implantable cardiac defibrillators [<xref ref-type="bibr" rid="CR42">42</xref>]. Nevertheless, as many as 51% of patients with JLN syndrome experience arrhythmic events despite current treatment options [<xref ref-type="bibr" rid="CR56">56</xref>]. Together with current suggestions for genotype-targeted therapy [<xref ref-type="bibr" rid="CR33">33</xref>], these considerations warrant correspondingly genotype-targeted investigations of arrhythmogenic mechanisms in the JLN variants.</p><p>Mouse models have previously provided good paradigms for a variety of genetic cardiac arrhythmia conditions [<xref ref-type="bibr" rid="CR27">27</xref>]. They have also permitted systematic identification and separation of the contrasting contributions made by ectopic and re-entrant arrhythmogenic mechanisms, as well as spatial and temporal components contributing to re-entry [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR65">65</xref>]. A mouse model of JLN2 has been developed previously by targeted homozygous deletion of the <italic>KCNE1</italic> gene [<xref ref-type="bibr" rid="CR68">68</xref>]. This model replicates the primary abnormalities observed in the human JLN syndrome in showing inner ear defects [<xref ref-type="bibr" rid="CR9">9</xref>] manifesting as shaker/waltzer movement disorders, as well as an increased tendency to ventricular arrhythmias compared to wild-type (WT) hearts [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR66">66</xref>].</p><p>The present study accordingly examined potential transmural mechanisms for ventricular arrhythmogenesis in this mouse model of JLN2 at the isolated whole organ level. We made monophasic action potential (MAP) recordings for quantitative analyses of changes in action potential waveforms in isolated whole hearts. This thus complemented previous electrocardiographic studies in intact animals [<xref ref-type="bibr" rid="CR9">9</xref>] in allowing for assessments of intrinsic cardiac properties independent of autonomic factors while preserving intercellular coupling and spatial electrophysiological characteristics. This permitted recordings of localized epicardial and endocardial waveforms in contrast to electrocardiographic studies that would have only represented voltage differences summed across the entire myocardium. Thus, it was possible to apply to <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts experimental tests applied on a previous occasion in a murine model for LQT3 [<xref ref-type="bibr" rid="CR17">17</xref>]. This made it possible to identify tendencies for spontaneous arrhythmogenicity manifesting as triggered activity and spontaneous VT, as well as assessing for provoked arrhythmogenic tendencies [<xref ref-type="bibr" rid="CR65">65</xref>]. It also made it possible to systematically apply and quantify criteria for <italic>spatial</italic> re-entrant substrates [<xref ref-type="bibr" rid="CR3">3</xref>] in the form of altered &#x02206;APD<sub>90</sub> [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR64">64</xref>] and local critical intervals for re-excitation [<xref ref-type="bibr" rid="CR44">44</xref>]. Finally, we could quantify criteria for <italic>temporal</italic> substrates [<xref ref-type="bibr" rid="CR72">72</xref>, <xref ref-type="bibr" rid="CR73">73</xref>] through a description of APD<sub>90</sub> alternans and APD<sub>90</sub> restitution properties [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR45">45</xref>].</p><p>It was possible next to assess the effect of pharmacological manipulations on all of these criteria as well as upon the observed arrhythmogenicity. Such experiments involved comparison of these features in both <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> and WT hearts in the presence or absence of nicorandil. Preliminary clinical reports had suggested that nicorandil may be antiarrhythmic in clinical LQTS [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR58">58</xref>], though this has not been investigated in the setting of LQTS specifically due to <italic>KCNE1</italic> mutations. Similar suggestions have also arisen from animal studies using experimental models of LQT1, LQT2, and LQT3 in the canine wedge [<xref ref-type="bibr" rid="CR57">57</xref>], LQT1 in the guinea pig [<xref ref-type="bibr" rid="CR76">76</xref>], and in a LQT model induced by disopyramide pretreatment [<xref ref-type="bibr" rid="CR12">12</xref>] in all of which repolarization had been delayed by pharmacological manipulations but have not been investigated in any arrhythmogenic model based upon <italic>KCNE1</italic> abnormalities.</p><p>An assessment of the effects of nicorandil in a model for JLN2 is important as pharmacological agents that are antiarrhythmic in one particular LQTS subtype may not act similarly in other subtypes [<xref ref-type="bibr" rid="CR55">55</xref>]. Nicorandil could potentially offset the delayed repolarization resulting from reduced delayed K<sup>+</sup> current observed in JLN in view of previous descriptions of nicorandil-mediated reductions in myocardial APD<sub>90</sub> in different cardiac preparations. The concentrations of nicorandil used in this study (100&#x000a0;nM to 20&#x000a0;&#x000b5;M) were based on established literature that has demonstrated such empirical actions of nicorandil in a variety of cardiac preparations. This may be through actions providing an enhanced repolarization reserve through increased K<sup>+</sup> conductance [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR60">60</xref>]. Nicorandil causes significant APD<sub>90</sub> shortening at the cellular level at concentrations of 10&#x000a0;&#x000b5;M in left atrial muscle fibres [<xref ref-type="bibr" rid="CR74">74</xref>], 1, 10, 30, and 100&#x000a0;&#x000b5;M in Purkinje fibres [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR75">75</xref>], and 10 and 100&#x000a0;&#x000b5;M in isolated guinea pig and rabbit ventricular myocytes [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR22">22</xref>] independently of external [Na<sup>+</sup>] [<xref ref-type="bibr" rid="CR18">18</xref>], and in the absence of alterations in Ca<sup>2+</sup> currents [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR22">22</xref>], maximum upstrokes of the action potential [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR22">22</xref>] and maximum diastolic membrane potentials ([<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR31">31</xref>] but see [<xref ref-type="bibr" rid="CR74">74</xref>]). It also shortens APD<sub>90</sub> at the tissue [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR76">76</xref>] and whole organ [<xref ref-type="bibr" rid="CR26">26</xref>] levels at 2 to 20&#x000a0;&#x000b5;M in canine LQT1, LQT2, and LQT3 pharmacological models [<xref ref-type="bibr" rid="CR57">57</xref>], at 5 to 30&#x000a0;&#x000b5;M in guinea pig hearts in the absence or presence of chromanol 293B [<xref ref-type="bibr" rid="CR76">76</xref>], at 20&#x000a0;&#x000b5;M in murine hypokalaemic hearts [<xref ref-type="bibr" rid="CR26">26</xref>], and at 10 to 20&#x000a0;&#x000b5;M in murine <italic>Scn5a</italic>+/&#x02206;KPQ hearts modeling LQT3 [<xref ref-type="bibr" rid="CR17">17</xref>].</p><p>The present findings establish empirically for the first time that nicorandil may have a useful antiarrhythmic role as reflected in its suppression of triggered activity, spontaneous VT, and provoked VT. They also demonstrate a parallel modification of recently introduced quantitative indicators of both spatial and temporal re-entrant substrates [<xref ref-type="bibr" rid="CR16">16</xref>]. In so doing, these studies also demonstrate an existence of abnormal restitution properties in the <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> system for the first time. Together, these findings implicate such features in the arrhythmogenic properties observed in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Materials and methods</title><sec id="Sec3"><title>Experimental animals</title><p><italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> mice were supplied by Vetter et al. [<xref ref-type="bibr" rid="CR68">68</xref>] and inbred upon the 129/Sv background. Breeding pairs of homozygotes and WTs were established and gave rise to lines of <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> and WT animals. Mice were housed at 21&#x02009;&#x000b1;&#x02009;1&#x000b0;C with 12&#x000a0;h light/dark cycles. Mice were fed sterile chow (RM3 Maintenance Diet, SDS, Witham, Essex, UK) and had free access to water at all times. Randomly selected male and female mice aged 5&#x02013;7&#x000a0;months were used for experiments. All procedures conformed to the UK Animals (Scientific Procedures) Act 1986.</p></sec><sec id="Sec4"><title>Heart isolation</title><p>A Langendorff-perfusion technique was used as previously described [<xref ref-type="bibr" rid="CR14">14</xref>]. Mice were killed by cervical dislocation (Schedule 1: Animals (Scientific Procedures) Act 1986). Hearts were exposed by bilateral sternotomy, rapidly excised, and a small section (3&#x02013;4&#x000a0;mm) of aorta was identified and cannulated in ice-cold, Krebs&#x02013;Henseleit solution using a custom-made 21-gauge cannula and secured using an aneurysm clip (Harvard Apparatus, Edenbridge, Kent, UK). Krebs&#x02013;Henseleit solution consisted of (in mM): NaCl 119, NaHCO<sub>3</sub> 25, KCl 4, KH<sub>2</sub>PO<sub>4</sub> 1.2, MgCl<sub>2</sub> 1, CaCl<sub>2</sub> 1.8, glucose 10, and Na pyruvate 2, pH 7.4, bubbled with 95% O<sub>2</sub>/5% CO<sub>2</sub> (British Oxygen Company, Manchester, UK). The isolated hearts were then transferred within 120&#x000a0;s from excision to the Langendorff-perfusion system. They were perfused retrogradely with Krebs&#x02013;Henseleit solution via the coronary arteries at a flow rate of 2.0&#x02013;2.5&#x000a0;mL/min using a peristaltic pump (Watson-Marlow Bredel Model 505S, Falmouth, Cornwall, UK). The perfusate had been passed through two, 200- and 5-mm, filters (Millipore, Watford, UK) and then heated to 37&#x000b0;C by a water-jacketed heat-exchange coil and circulator (Ecolin Staredition E100, Lauda, Lauda-K&#x000f6;nigshofen, Germany). Healthy hearts regained a healthy pink colour and contracted spontaneously. Approximately 10% of hearts were discarded due to signs of ischaemia.</p></sec><sec id="Sec5"><title>Perfused heart electrophysiology</title><p>MAPs were recorded from the epicardial and endocardial surfaces of the left ventricular free wall. Epicardial recordings were made with a MAP electrode (Linton Instruments, Harvard Apparatus, UK) designed for rodent hearts and positioned against the basal left ventricular epicardial surface. Endocardial recordings were made using a custom-made MAP electrode constructed from Teflon-coated silver wire of 0.25&#x000a0;mm diameter (Advent Research Materials, UK) and 99.99% purity. The final 1&#x000a0;mm of Teflon coating was removed from the electrode tips, which were then galvanically chlorided to avoid DC offset. An aperture was carefully made in the interventricular septum to allow the electrode to be positioned against the left ventricular endocardial free wall. MAP waveforms were quantified to determine APD<sub><italic>x</italic></sub>, the time taken for repolarization to <italic>x</italic>%, thus permitting the quantification of APD<sub>30</sub>, APD<sub>50</sub>, APD<sub>70</sub>, and APD<sub>90</sub>. MAPs met previously established criteria including a rapid upstroke, smooth contoured repolarization phase, and a stable baseline [<xref ref-type="bibr" rid="CR28">28</xref>]. Peak depolarization (0% repolarization) was considered to be the most positive point of deflection above the baseline, while 100% repolarization was considered to be the point of return to baseline [<xref ref-type="bibr" rid="CR25">25</xref>]. MAP signals were preamplified with a NL100AK head stage and band pass filtered (0.5&#x000a0;Hz to 1&#x000a0;kHz; Neurolog NL 125/6 Filter, Neurolog, Hertfordshire, UK). A micro 1401plus MKII laboratory interface (Cambridge Electronic Design, Cambridge, UK) was used to digitize these signals at a sampling frequency of 5&#x000a0;kHz. Spike2 software (Cambridge Electronic Design, Cambridge, UK) was used to analyze MAP waveforms.</p></sec><sec id="Sec6"><title>Experimental protocol</title><p>Hearts were stimulated from the basal right ventricular epicardium with a bipolar platinum electrode with 1&#x000a0;mm interpole distance. Square-wave stimuli (Grass S48 Stimulator, Grass-Telefactor, Slough, UK) of 2&#x000a0;ms duration and three times the diastolic threshold [<xref ref-type="bibr" rid="CR25">25</xref>] were applied at a basic cycle length (BCL) of 125&#x000a0;ms corresponding to murine whole heart physiological heart rates [<xref ref-type="bibr" rid="CR41">41</xref>]. Hearts were initially paced for at least 10&#x000a0;min at a constant BCL of 125&#x000a0;ms to reach a steady-state. Following this initial equilibration period, both spontaneous and provoked arrhythmogenesis were assessed in the absence and presence of nicorandil. VT was defined as five or more consecutive premature MAPs [<xref ref-type="bibr" rid="CR25">25</xref>]. Spontaneous arrhythmogenic properties were assessed in the absence of extrinsic pacing. Provoked arrhythmogenesis was assessed using a programmed electrical stimulation (PES) method adapted from clinical practice [<xref ref-type="bibr" rid="CR51">51</xref>] and previously applied to murine hearts [<xref ref-type="bibr" rid="CR14">14</xref>]. The PES protocol consisted of cycles of 8 S1 stimuli applied at a BCL of 125&#x000a0;ms, followed by a S2 extrastimulus. The S1-S2 stimulus interval began at 125&#x000a0;ms and decreased by 1&#x000a0;ms with each successive cycle of eight S1 stimuli. This extrasystolic protocol also enabled the quantification of ventricular effective refractory periods (VERPs) from the longest S1&#x02013;S2 interval that failed to elicit a MAP. Action potential durations (APDs) and stimulus-depolarization conduction latencies were quantified during steady-state pacing at a 125&#x000a0;ms BCL [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR64">64</xref>]. A dynamic pacing protocol (see the &#x0201c;<xref rid="Sec9" ref-type="sec">Results</xref>&#x0201d; section) was used to assess temporal properties allowing the examination of APD<sub>90</sub> alternans and APD<sub>90</sub> restitution properties.</p></sec><sec id="Sec7"><title>Pharmacological agents</title><p>Drug-containing solutions were made by adding nicorandil (Tocris Bioscience, UK) from 10&#x000a0;mM stock solutions made up in doubly distilled water, to Krebs&#x02013;Henseleit solution, and serially diluted to the target concentrations (100&#x000a0;nM, 1&#x000a0;&#x000b5;M, 10&#x000a0;&#x000b5;M, and 20&#x000a0;&#x000b5;M).</p></sec><sec id="Sec8"><title>Data analysis and statistics</title><p>Data are presented as the means&#x000b1;standard error of the means together with the number of hearts (<italic>n</italic>). Categorical data were compared using Fisher&#x02019;s exact test (one-tailed), and continuous data were compared using analysis of variance (SPSS software) and Student&#x02019;s unpaired <italic>t</italic> test as appropriate. <italic>P</italic> values less than 0.05 were considered significant. Curve fitting to experimental restitution data sets was performed using a Levenberg&#x02013;Marquardt algorithm (Origin 8, OriginLab, MA, USA).</p></sec></sec><sec id="Sec9" sec-type="results"><title>Results</title><p>Langendorff preparations of murine hearts were initially perfused using control Krebs&#x02013;Henseleit solution and MAP recordings were then made following 10&#x000a0;min of such perfusion. Recordings made in the presence of nicorandil were similarly made following 10&#x000a0;min of perfusion with nicorandil-containing Krebs&#x02013;Henseleit solution. Hearts were first investigated during intrinsic activity for assessment of <italic>spontaneous</italic> arrhythmogenic properties. They were then investigated for <italic>provoked</italic> arrhythmogenesis using a PES protocol [<xref ref-type="bibr" rid="CR4">4</xref>]. MAP waveforms were recorded and assessed from the left ventricular epicardium and endocardium during steady-state 8-Hz pacing as on previous occasions in the mouse heart [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Finally, dynamic repolarization properties were investigated using a dynamic pacing protocol.</p><sec id="Sec10"><title>Triggered activity and spontaneous arrhythmogenesis in intrinsically beating <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts</title><p>Intrinsically beating <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts perfused with control solution demonstrated triggered activity, observed as ectopic MAP waveforms in nine out of ten hearts (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>a). Such activity typically occurred immediately following or just prior to MAP repolarization in agreement with the timing of afterdepolarization phenomena described on earlier occasions [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. These abnormalities were absent in intrinsically beating WT hearts (<italic>n</italic>&#x02009;=&#x02009;5) (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>b). We then tested the effect of nicorandil upon the occurrence of triggered activity. Nicorandil (20&#x000a0;&#x000b5;M) suppressed triggered activity in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>c), while in WT hearts, there remained a total absence of such triggered electrical activity (<italic>n</italic>&#x02009;=&#x02009;7 and 5, <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> and WT hearts, respectively) (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>d). <fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Representative MAP recordings from intrinsically beating <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts Langendorff-perfused with control Krebs&#x02013;Henseleit solution demonstrating typical spontaneous triggered activity occurring as ectopic MAP waveforms (<italic>asterisk</italic>) in association with the onset of spontaneous VT (<bold>a</bold>) in contrast to their absence in similarly perfused intrinsically beating WT hearts (<bold>b</bold>). Treatment with 20&#x000a0;&#x000b5;M nicorandil reduced both triggered activity and VT in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts (<bold>c</bold>). WT hearts treated with nicorandil did not show triggered activity or VT (<bold>d</bold>)</p></caption><graphic position="anchor" xlink:href="424_2009_671_Fig1_HTML" id="MO1"/></fig></p><p>Following these preliminary observations of the effects of 20&#x000a0;&#x000b5;M nicorandil, we proceeded to investigate the effect of a range of nicorandil concentrations (100&#x000a0;nM, 1&#x000a0;&#x000b5;M, 10&#x000a0;&#x000b5;M, and 20&#x000a0;&#x000b5;M) upon triggered activity in intrinsically beating hearts. The incidence of such activity was determined from randomly selected 10&#x000a0;s sampling periods in each heart at any given nicorandil concentration from MAP recordings in each heart (consisting of 211&#x02009;&#x000b1;&#x02009;67 and 337&#x02009;&#x000b1;&#x02009;80 MAPs per heart, WT and <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup>, respectively). Nicorandil treatment was associated with a concentration-dependent reduction in the incidence of triggered activity in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts. Thus, the proportion of ectopic MAP waveforms decreased from 28.1&#x02009;&#x000b1;&#x02009;8.4% in hearts perfused with control solution (<italic>n</italic>&#x02009;=&#x02009;10) to 20.9&#x02009;&#x000b1;&#x02009;10.9% at 100&#x000a0;nM (<italic>n</italic>&#x02009;=&#x02009;5, <italic>P</italic>&#x02009;&#x0003e;&#x02009;0.05), 20.5&#x02009;&#x000b1;&#x02009;10.9% at 1&#x000a0;&#x000b5;M (<italic>n</italic>&#x02009;=&#x02009;5, <italic>P</italic>&#x02009;&#x0003e;&#x02009;0.05), 2.2&#x02009;&#x000b1;&#x02009;2.1% at 10&#x000a0;&#x000b5;M (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05; <italic>n</italic>&#x02009;=&#x02009;5), and 0.9&#x02009;&#x000b1;&#x02009;1.1 at 20&#x000a0;&#x000b5;M nicorandil (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01; <italic>n</italic>&#x02009;=&#x02009;7) (all comparisons performed against untreated hearts). WT hearts did not show triggered activity anywhere in the range of nicorandil concentrations (<italic>n</italic>&#x02009;=&#x02009;5 at each concentration).</p><p>These ectopic waveforms frequently occurred in association with runs of spontaneous VT, defined as five or more premature MAP waveforms [<xref ref-type="bibr" rid="CR25">25</xref>], in intrinsically beating <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>a). The incidence of VT was determined by analyzing MAP waveforms recorded from such intrinsically beating hearts. Spontaneous VT occurred in six out of ten untreated <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> versus none out of five untreated WT hearts, demonstrating a significant tendency to spontaneous VT in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> compared to WT hearts (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05; Fisher&#x02019;s exact test). In contrast, during treatment with nicorandil (20&#x000a0;&#x000b5;M), spontaneous VT was not seen in any <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> or WT hearts (<italic>n</italic>&#x02009;=&#x02009;7 and 5, for <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts and WT hearts, respectively), demonstrating a significant antiarrhythmic effect of nicorandil upon spontaneous VT (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05; Fisher&#x02019;s exact test).</p></sec><sec id="Sec11"><title>Provoked arrhythmogenesis in <italic>KCNE1</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> hearts</title><p>We then investigated tendencies to <italic>provoked</italic> arrhythmogenesis using an established PES protocol adapted from clinical practice [<xref ref-type="bibr" rid="CR51">51</xref>] and successfully applied in murine cardiac systems [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. The protocol consisted of cycles of eight S1 stimuli at a frequency of 8&#x000a0;Hz, with each cycle followed by an extrastimulus, S2, initially 125&#x000a0;ms after the preceding S1 stimulus. This S1&#x02013;S2 stimulus was then progressively reduced by 1&#x000a0;ms with each cycle until hearts were either refractory to the S2 or VT was initiated. PES resulted in VT in five out of five untreated <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>a) in contrast to none of five untreated WT hearts that were totally refractory to such provocation (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>b). We then assessed the effect of a range of concentrations of nicorandil (100&#x000a0;nM, 1&#x000a0;&#x000b5;M, 10&#x000a0;&#x000b5;M, and 20&#x000a0;&#x000b5;M) on this arrhythmogenicity. PES resulted in VT in five out of five hearts at 100&#x000a0;nM and 1&#x000a0;&#x000b5;M nicorandil. Higher concentrations of nicorandil (10 and 20&#x000a0;&#x000b5;M) reduced this incidence to one out of five hearts (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>c), demonstrating a significant antiarrhythmic effect against PES-induced arrhythmogenesis (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05 versus untreated hearts; Fisher&#x02019;s exact test). WT hearts remained refractory to provocation by PES at all concentrations used (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>d) (<italic>n</italic>&#x02009;=&#x02009;5). <fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>MAP recordings obtained during a PES protocol used to assess for provoked arrhythmogenic tendencies. They demonstrate the typical initiation of VT in untreated <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts observed in five out of five hearts (<bold>a</bold>) and the prevention of such VT by treatment with nicorandil (20&#x000a0;&#x000b5;M) in four out of five hearts (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) (<bold>c</bold>). WT hearts were refractory to PES provocation whether untreated (<bold>b</bold>) or treated with nicorandil (<bold>d</bold>)</p></caption><graphic position="anchor" xlink:href="424_2009_671_Fig2_HTML" id="MO2"/></fig></p><p>Previous reports have described sex-linked differences in arrhythmogenic phenotype in a number of congenital arrhythmic conditions [<xref ref-type="bibr" rid="CR2">2</xref>]. Our study did not detect significant differences in findings between male and female <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts. Thus, triggered activity was seen in six of seven male and three of three female untreated hearts. Spontaneous VT was seen in four of seven males and two of three females. PES induced VT in three of three males and two of two females. This is consistent with a previous report [<xref ref-type="bibr" rid="CR4">4</xref>] that investigated <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts with bipolar electrograms, but not MAP recordings, in which untreated <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts were all arrhythmic (five males and five females) with PES. Our results showed that nicorandil (20&#x000a0;&#x000b5;M) produced similar actions upon <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> mice whether male or female. Triggered activity was observed in just one of five male and zero of two female nicorandil-treated hearts. Spontaneous VT was observed in zero of five males and zero of two females studied. VT was then provoked by PES in one of three male and zero of two female hearts. In contrast, none of two male and three female untreated WT hearts showed evidence for triggered activity or spontaneous VT. None of three male and two female untreated WT hearts showed PES-induced VT. Following the introduction of 20&#x000a0;&#x000b5;M nicorandil, none of two male and three female hearts showed either triggered activity or spontaneous VT, nor did any of two male or three female WT hearts show PES-induced VT. Furthermore, there was no evidence for sex-linked differences in VERP in either <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> or WT hearts. Thus, male and female animals gave VERPs of 28.8&#x02009;&#x000b1;&#x02009;2.7 and 30.5&#x02009;&#x000b1;&#x02009;5.1&#x000a0;ms in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts and 25.6&#x02009;&#x000b1;&#x02009;2.5 and 27.5&#x02009;&#x000b1;&#x02009;3.5&#x000a0;ms in WT hearts, respectively. Following the addition of nicorandil, the respective values were 32.0&#x02009;&#x000b1;&#x02009;3.2 and 28.0&#x02009;&#x000b1;&#x02009;9.0&#x000a0;ms in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> and 25.7&#x02009;&#x000b1;&#x02009;0.5 and 29.5&#x02009;&#x000b1;&#x02009;2.5&#x000a0;ms in WT hearts, respectively.</p></sec><sec id="Sec12"><title>Epicardial and endocardial MAP waveforms in WT and <italic>KCNE1</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> hearts</title><p>Previous studies have investigated epicardial and endocardial action potential waveforms in murine models of inherited LQTS [<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR65">65</xref>] and hypokalaemic LQTS [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR25">25</xref>] and suggested that alterations in the durations of epicardial waveforms compared to endocardial waveforms may be associated with altered arrhythmogenic tendencies. We, therefore, proceeded to quantify APDs in both untreated and nicorandil-treated hearts to investigate the underlying basis of arrhythmic phenomena for the first time in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts. Representative epicardial and endocardial MAP waveforms in WT and <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts recorded in the absence and presence of 20&#x000a0;&#x000b5;M nicorandil are shown in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>. This demonstrates the typically prolonged epicardial MAP waveform in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> compared to WT hearts and also demonstrates the shortened epicardial MAP waveforms in both <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> and WT hearts perfused with nicorandil. APDs at <italic>x</italic>% repolarization (APD<sub><italic>x</italic></sub>) were quantified during steady-state 8&#x000a0;Hz extrinsic pacing (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>) approximating typical physiological murine heart rates [<xref ref-type="bibr" rid="CR41">41</xref>]. In the epicardium of untreated <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts, APD<sub>90</sub> and APD<sub>70</sub> were significantly longer than in the epicardium of untreated WT hearts. Thus, APD<sub>90</sub> was 55.1&#x02009;&#x000b1;&#x02009;1.0 versus 40. 9&#x02009;&#x000b1;&#x02009;1.5&#x000a0;ms (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001; <italic>n</italic>&#x02009;=&#x02009;5 and 5) and APD<sub>70</sub> was 30.7&#x02009;&#x000b1;&#x02009;1.9 versus 21.4&#x02009;&#x000b1;&#x02009;1.4&#x000a0;ms (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01; <italic>n</italic>&#x02009;=&#x02009;5 and 5) in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> and WT hearts, respectively. In contrast to these epicardial findings, there was no difference in endocardial APD between untreated <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> and WT hearts. Endocardial APD<sub>90</sub> was 51.3&#x02009;&#x000b1;&#x02009;1.4 and 51.0&#x02009;&#x000b1;&#x02009;1.2&#x000a0;ms in untreated <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> and WT hearts, respectively (<italic>P</italic>&#x02009;&#x0003e;&#x02009;0.05; <italic>n</italic>&#x02009;=&#x02009;5 in both cases). <fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>Representative MAP waveforms during steady-state 8-Hz pacing recorded from the left ventricular epicardia and endocardia of <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> (<bold>a</bold> and <bold>c</bold>) and WT (<bold>b</bold> and <bold>d</bold>) hearts perfused with control solution (<bold>a</bold> and <bold>b</bold>) or 20&#x000a0;&#x000b5;M nicorandil (<bold>c</bold> and <bold>d</bold>). <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts had longer epicardial MAP waveforms (<bold>a</bold>) than WTs similarly perfused with control solution (<bold>b</bold>), and both were shortened by nicorandil (<bold>c</bold> and <bold>d</bold>) while endocardial MAPs were conserved in both (<bold>c</bold> and <bold>d</bold>)</p></caption><graphic position="anchor" xlink:href="424_2009_671_Fig3_HTML" id="MO3"/></fig><fig id="Fig4"><label>Fig.&#x000a0;4</label><caption><p>APD at 30%, 50%, 70%, and 90% repolarization quantified from MAP recordings made from the epicardium of <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> (<bold>a</bold>) and WT (<bold>b</bold>) hearts during 8-Hz extrinsic pacing demonstrated a concentration-dependent reduction in APD<sub>90</sub> and APD<sub>70</sub> with nicorandil. In contrast, similarly obtained MAP recordings from the endocardium of <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> (<bold>c</bold>) and WT (<bold>d</bold>) hearts demonstrated conserved APD values during perfusion with nicorandil (*<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05; **<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01; ***<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001)</p></caption><graphic position="anchor" xlink:href="424_2009_671_Fig4_HTML" id="MO4"/></fig></p><p>We also determined the effect of a range of concentrations of nicorandil (100&#x000a0;nM, 1&#x000a0;&#x000b5;M, 10&#x000a0;&#x000b5;M, and 20&#x000a0;&#x000b5;M) upon APD in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts. In the epicardium of <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts, APD<sub>90</sub> was reduced by nicorandil to 51.1&#x02009;&#x000b1;&#x02009;0.9, 44.5&#x02009;&#x000b1;&#x02009;2.2, and 38.9&#x02009;&#x000b1;&#x02009;1.8&#x000a0;ms during treatment with 1, 10, and 20&#x000a0;&#x000b5;M nicorandil (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001, and <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001 versus untreated <italic>KCNE1</italic> hearts at 1, 10, and 20&#x000a0;&#x000b5;M, respectively). In WT hearts, epicardial APD<sub>90</sub> was also shortened by nicorandil to 35.6&#x02009;&#x000b1;&#x02009;1.5 and 33.8&#x02009;&#x000b1;&#x02009;0.9&#x000a0;ms at 10 and 20&#x000a0;&#x000b5;M nicorandil, respectively (10&#x000a0;&#x000b5;M, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05; 20&#x000a0;&#x000b5;M, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001; <italic>n</italic>&#x02009;=&#x02009;5 in all cases). In contrast, endocardial APD<sub>90</sub> was not changed by nicorandil in either <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> or WT hearts. Thus, during perfusion with 20&#x000a0;&#x000b5;M nicorandil, endocardial APD<sub>90</sub> was 53.5&#x02009;&#x000b1;&#x02009;1.5 and 50.6&#x02009;&#x000b1;&#x02009;1.2&#x000a0;ms in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> and WT hearts, respectively (<italic>n</italic>&#x02009;=&#x02009;5 in all cases; <italic>P</italic>&#x02009;&#x0003e;&#x02009;0.05 versus untreated hearts of the same genotype).</p><p>These findings demonstrate preferential abnormalities in epicardial APD<sub>90</sub> and conserved endocardial APD<sub>90</sub> in parallel with increased arrhythmic tendencies in untreated <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts. These findings together complement previous observations in a model of LQT3 [<xref ref-type="bibr" rid="CR64">64</xref>] and the hypokalaemic murine heart [<xref ref-type="bibr" rid="CR25">25</xref>]. The present findings further show that nicorandil altered these <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> MAP waveform characteristics toward those found in untreated WTs.</p></sec><sec id="Sec13"><title>Transmural gradients of repolarization in WT and <italic>KCNE1</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> hearts</title><p>The ventricular wall has been shown to possess heterogeneities in APD, not only in the murine heart [<xref ref-type="bibr" rid="CR69">69</xref>] but also in larger hearts such as the canine heart [<xref ref-type="bibr" rid="CR3">3</xref>]. It has been suggested that such regional differences in APD are due to heterogeneities in spatial patterns of repolarization [<xref ref-type="bibr" rid="CR3">3</xref>] resulting from transmural gradients of ion channel expression [<xref ref-type="bibr" rid="CR52">52</xref>]. In the murine system, the transmural gradient of repolarization, &#x02206;APD<sub>90</sub>, given by the difference between endocardial and epicardial APD<sub>90</sub>, has been used to explore for spatial substrates for re-entrant excitation [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>].</p><p>We initially determined epicardial and endocardial activation times, which reflect the time taken from ventricular electrical stimulation to peak depolarization. We were able to quantify activation times from MAP recordings by measuring the latent period between electrical stimulation and the peak of the MAP. Activation times were 17.3&#x02009;&#x000b1;&#x02009;1.3 and 16.4&#x02009;&#x000b1;&#x02009;1.7&#x000a0;ms in the epicardium and endocardium of untreated <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts, respectively, and did not significantly differ. Activation times were 16.1&#x02009;&#x000b1;&#x02009;1.1 and 17.9&#x02009;&#x000b1;&#x02009;1.1&#x000a0;ms in the epicardium and endocardium of untreated WT hearts (<italic>n</italic>&#x02009;=&#x02009;5 in all cases), respectively, which also did not differ significantly. Following treatment with 20&#x000a0;&#x000b5;M nicorandil, activation times in the epicardium and endocardium were 16.8&#x02009;&#x000b1;&#x02009;1.2 and 17.4&#x02009;&#x000b1;&#x02009;1.3&#x000a0;ms in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts and 19.1&#x02009;&#x000b1;&#x02009;1.8 and 15.7&#x02009;&#x000b1;&#x02009;1.0&#x000a0;ms in the epicardium and endocardium of WT hearts (<italic>n</italic>&#x02009;=&#x02009;5 in all cases), respectively, which also did not differ significantly. Finally, epicardial or endocardial activation times both did not differ between <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> and WT hearts, whether in untreated hearts or in those treated with 20&#x000a0;&#x000b5;M nicorandil. Thus, changes in arrhythmogenicity were not associated with detectable changes in activation times. Furthermore, in the absence of significant differences in activation times, we were able to represent the transmural gradient of repolarization by &#x00394;APD<sub>90</sub> as on previous occasions in the murine heart [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR25">25</xref>].</p><p>Figure&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref> shows the &#x02206;APD<sub>90</sub> values for <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> and WT hearts in the absence and presence of nicorandil. In untreated <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts, &#x02206;APD<sub>90</sub> was &#x02212;3.8&#x02009;&#x000b1;&#x02009;1.7&#x000a0;ms (<italic>n</italic>&#x02009;=&#x02009;5), significantly smaller (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) than in untreated WT hearts where &#x02206;APD<sub>90</sub> was 10.9&#x02009;&#x000b1;&#x02009;1.9&#x000a0;ms (<italic>n</italic>&#x02009;=&#x02009;5). Nicorandil resulted in a concentration-dependent increase in &#x02206;APD<sub>90</sub> in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts, reaching significance at 10 and 20&#x000a0;&#x000b5;M nicorandil, with &#x02206;APD<sub>90</sub>s of 5.1&#x02009;&#x000b1;&#x02009;2.9 and 14.6&#x02009;&#x000b1;&#x02009;2.4&#x000a0;ms at 10 and 20&#x000a0;&#x000b5;M, respectively (10&#x000a0;&#x000b5;M, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05; 20&#x000a0;&#x000b5;M, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001). This concentration range was similar to that at which spontaneous and provoked arrhythmogenic phenomena were reduced and at which epicardial APD<sub>90</sub> was shortened. In WT hearts, nicorandil also concentration-dependently increased &#x02206;APD<sub>90</sub> in WT hearts, reaching statistical significance at 10 and 20&#x000a0;&#x000b5;M. In WT hearts, &#x02206;APD<sub>90</sub> was increased to 17.3&#x02009;&#x000b1;&#x02009;1.7 (<italic>n</italic>&#x02009;=&#x02009;5) and 16.9&#x02009;&#x000b1;&#x02009;1.5&#x000a0;ms (<italic>n</italic>&#x02009;=&#x02009;5) at 10 and 20&#x000a0;&#x000b5;M nicorandil (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05 in both cases), respectively. <fig id="Fig5"><label>Fig.&#x000a0;5</label><caption><p>The transmural gradient of repolarization, &#x02206;APD<sub>90</sub>, determined from endocardial and epicardial MAP recordings during 8-Hz extrinsic pacing through a range of nicorandil concentrations in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> (<bold>a</bold>) and WT hearts (<bold>b</bold>) (*<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05; ***<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001)</p></caption><graphic position="anchor" xlink:href="424_2009_671_Fig5_HTML" id="MO5"/></fig></p></sec><sec id="Sec14"><title>Critical intervals for local re-excitation in WT and <italic>KCNE1</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> hearts</title><p>Recent studies in the hypokalaemic murine heart have suggested that the interval between APD<sub>90</sub> and VERP reflects the likelihood for local re-excitation and that reductions in this interval may be antiarrhythmic [<xref ref-type="bibr" rid="CR44">44</xref>]. We accordingly investigated this relationship in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts for the first time. Figure&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref> shows such critical intervals over a range of nicorandil concentrations in hearts paced at 8&#x000a0;Hz. In untreated <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts, the epicardial critical interval was significantly greater than in untreated WT hearts, 25.3&#x02009;&#x000b1;&#x02009;3.3 versus 14.7&#x02009;&#x000b1;&#x02009;2.2&#x000a0;ms in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> and WT hearts, respectively (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05; <italic>n</italic>&#x02009;=&#x02009;5). We then investigated the effect of nicorandil upon such intervals (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>). Nicorandil produced a concentration-dependent reduction in local critical intervals for re-excitation, reaching significance at 20&#x000a0;&#x000b5;M nicorandil with a critical interval of 8.2&#x02009;&#x000b1;&#x02009;3.8&#x000a0;ms (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01 versus untreated <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts; <italic>n</italic>&#x02009;=&#x02009;5). Nicorandil also produced concentration-dependent reductions in critical intervals in WT hearts, reaching significance at 20&#x000a0;&#x000b5;M with a critical interval of 7.5&#x02009;&#x000b1;&#x02009;2.4&#x000a0;ms (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05 versus untreated WT hearts; <italic>n</italic>&#x02009;=&#x02009;5). Thus, the enhanced arrhythmogenicity in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts compared to WT hearts was accompanied by larger critical intervals for local re-excitation. Furthermore, nicorandil produced reductions in local critical intervals in parallel with its antiarrhythmic effect in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts and alongside the lack of arrhythmia inducibility in WT hearts. <fig id="Fig6"><label>Fig.&#x000a0;6</label><caption><p>Comparison of epicardial APD<sub>90</sub>, VERP, and local critical intervals for re-excitation measured during steady 8-Hz extrinsic pacing over a range of nicorandil concentrations in the epicardium of <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> (<bold>a</bold>) and WT (<bold>b</bold>) hearts (*<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05; **<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01; ***<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001). APD<sub>90</sub> data set from Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref></p></caption><graphic position="anchor" xlink:href="424_2009_671_Fig6_HTML" id="MO6"/></fig></p></sec><sec id="Sec15"><title>The magnitude of APD<sub>90</sub> alternans in WT and <italic>KCNE1</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> hearts</title><p>Alternations in APD<sub>90</sub> have been associated with a variety of arrhythmias in human [<xref ref-type="bibr" rid="CR54">54</xref>] and animal studies [<xref ref-type="bibr" rid="CR45">45</xref>]. We used a dynamic pacing protocol to assess APD<sub>90</sub> properties over a range of BCLs [<xref ref-type="bibr" rid="CR29">29</xref>]. This protocol consisted of cycles consisting of 100 stimuli at each BCL, starting with a BCL of 190&#x000a0;ms and reduced by 5&#x000a0;ms decrements with each successive cycle down to a final BCL of 65&#x000a0;ms. The final 50 action potentials within each cycle of 100 action potentials at any particular BCL yielded steady-state recordings that were analyzed to determine APD<sub>90</sub> values, as in a previous study in the hypokalaemic murine heart [<xref ref-type="bibr" rid="CR45">45</xref>]. Firstly, in all hearts, alternans in both epicardial and endocardial MAPs increased as BCL decreased (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>). Secondly, successive values of APD<sub>90</sub> alternans in untreated <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>, squares) tended consistently to fall above corresponding points obtained in WT hearts (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>, triangles) through the investigated range of BCLs. This trend applied for both epicardial (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>a) and endocardial values (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>b). Finally, treatment with 20&#x000a0;&#x000b5;M nicorandil reduced such differences in alternans between <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> and WT hearts in both epicardium (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>c) and endocardium (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>d). <fig id="Fig7"><label>Fig.&#x000a0;7</label><caption><p>APD<sub>90</sub> alternans recorded over a range of BCLs from the epicardium (<bold>a</bold> and <bold>c</bold>) and endocardium (<bold>b</bold> and <bold>d</bold>) of untreated (<bold>a</bold> and <bold>b</bold>) and nicorandil-treated (20&#x000a0;&#x000b5;M) (<bold>c</bold> and <bold>d</bold>) <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> (<bold>a</bold> and <bold>c</bold>) and WT (<bold>b</bold> and <bold>d</bold>) hearts</p></caption><graphic position="anchor" xlink:href="424_2009_671_Fig7_HTML" id="MO7"/></fig></p></sec><sec id="Sec16"><title>APD<sub>90</sub> restitution properties in WT and <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts</title><p>Increases in the steepness of APD<sub>90</sub> restitution curves have been reported to associate with enhanced arrhythmogenicity in both clinical reports [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR63">63</xref>] and experimental systems [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. APD<sub>90</sub> restitution properties have been investigated by plotting APD<sub>90</sub> versus the preceding diastolic interval (DI) [<xref ref-type="bibr" rid="CR39">39</xref>]. We accordingly proceeded to investigate restitution properties in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts and constructed APD<sub>90</sub> restitution curves using experimental data obtained from both epicardium and endocardium using a dynamic pacing protocol for the first time in this system, thereby allowing comparison with other murine arrhythmic models to which this method has been applied [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. Furthermore, we then tested the effect of nicorandil on APD<sub>90</sub> restitution properties in <italic>any</italic> model of JLN for the first time.</p><p>Figure&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref> shows restitution curves obtained from the epicardium of <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> and WT hearts perfused with either control solution or after treatment with 20&#x000a0;&#x000b5;M nicorandil. Similarly obtained restitution curves obtained from the endocardium of <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> and WT hearts perfused with either control solution or after treatment with 20&#x000a0;&#x000b5;M nicorandil are shown in Fig.&#x000a0;<xref rid="Fig9" ref-type="fig">9</xref>. <fig id="Fig8"><label>Fig.&#x000a0;8</label><caption><p>Epicardial restitution curves recorded from the epicardium of <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> (<bold>a</bold> and <bold>c</bold>) and WT (<bold>b</bold> and <bold>d</bold>) hearts perfused with control solution (<bold>a</bold> and <bold>b</bold>) or 20&#x000a0;&#x000b5;M nicorandil (<bold>c</bold> and <bold>d</bold>)</p></caption><graphic position="anchor" xlink:href="424_2009_671_Fig8_HTML" id="MO8"/></fig><fig id="Fig9"><label>Fig.&#x000a0;9</label><caption><p>Endocardial restitution curves recorded from the endocardium of <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> (<bold>a</bold> and <bold>c</bold>) and WT (<bold>b</bold> and <bold>d</bold>) hearts perfused with control solution (<bold>a</bold> and <bold>b</bold>) or 20&#x000a0;&#x000b5;M nicorandil (<bold>c</bold> and <bold>d</bold>)</p></caption><graphic position="anchor" xlink:href="424_2009_671_Fig9_HTML" id="MO9"/></fig></p><p>Such curves were fitted with a monoexponential curve [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR45">45</xref>] of the form: <disp-formula id="Equ1"><label>1</label><tex-math id="M1">\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ y = y_0 + A\left( {1 - e^{{{{ - x} \mathord{\left/ {\vphantom {{ - x} \tau }} \right. } \tau }}} } \right). $$\end{document}</tex-math></disp-formula></p><p>Empirical data points were fitted using a Levenberg&#x02013;Marquardt algorithm [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. The gradients of the fitted functions are also shown in Figs.&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref> and <xref rid="Fig9" ref-type="fig">9</xref>, given by the following function: <disp-formula id="Equ2"><label>2</label><tex-math id="M2">\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ \frac{{{\text{d}}y}}{{{\text{d}}x}} = \frac{A}{\tau }e^{{{{ - x} \mathord{\left/ {\vphantom {{ - x} \tau }} \right. } \tau }}} . $$\end{document}</tex-math></disp-formula></p><p>The parameters used in curve fitting for the epicardial and endocardial restitution data sets are shown in Tables&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> and <xref rid="Tab2" ref-type="table">2</xref>. <table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Parameters used in curve fitting to experimentally obtained epicardial APD<sub>90</sub> restitution data sets</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th><italic>n</italic></th><th><italic>y</italic><sub>0</sub> (ms)</th><th><italic>A</italic> (ms)</th><th><italic>&#x003c4;</italic> (ms)</th><th><italic>&#x003c7;</italic><sup>2</sup></th><th>CDI (ms)</th><th>Maximum gradient</th></tr></thead><tbody><tr><td><italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup></td><td char="." align="char">6</td><td char="&#x000b1;" align="char">&#x02212;75.71&#x02009;&#x000b1;&#x02009;13.56</td><td char="&#x000b1;" align="char">142.78&#x02009;&#x000b1;&#x02009;12.75</td><td char="&#x000b1;" align="char">29.06&#x02009;&#x000b1;&#x02009;2.22</td><td char="." align="char">0.164</td><td char="&#x000b1;" align="char">46.26&#x02009;&#x000b1;&#x02009;6.48</td><td char="&#x000b1;" align="char">1.32&#x02009;&#x000b1;&#x02009;0.18</td></tr><tr><td><italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup>+20&#x000a0;&#x000b5;M nicorandil</td><td char="." align="char">6</td><td char="&#x000b1;" align="char">&#x02212;4.18&#x02009;&#x000b1;&#x02009;6.56</td><td char="&#x000b1;" align="char">68.33&#x02009;&#x000b1;&#x02009;2.80</td><td char="&#x000b1;" align="char">68.48&#x02009;&#x000b1;&#x02009;16.28</td><td char="." align="char">0.152</td><td char="&#x000b1;" align="char">&#x02212;0.15&#x02009;&#x000b1;&#x02009;0.05</td><td char="&#x000b1;" align="char">0.55&#x02009;&#x000b1;&#x02009;0.04</td></tr><tr><td>WT</td><td char="." align="char">6</td><td char="&#x000b1;" align="char">&#x02212;7.04&#x02009;&#x000b1;&#x02009;2.53</td><td char="&#x000b1;" align="char">63.77&#x02009;&#x000b1;&#x02009;1.62</td><td char="&#x000b1;" align="char">53.06&#x02009;&#x000b1;&#x02009;3.95</td><td char="." align="char">0.095</td><td char="&#x000b1;" align="char">9.76&#x02009;&#x000b1;&#x02009;1.06</td><td char="&#x000b1;" align="char">0.59&#x02009;&#x000b1;&#x02009;0.02</td></tr><tr><td>WT+20&#x000a0;&#x000b5;M nicorandil</td><td char="." align="char">6</td><td char="&#x000b1;" align="char">10.6&#x02009;&#x000b1;&#x02009;1.5</td><td char="&#x000b1;" align="char">50.0&#x02009;&#x000b1;&#x02009;4.0</td><td char="&#x000b1;" align="char">136.2&#x02009;&#x000b1;&#x02009;27.8</td><td char="." align="char">0.060</td><td char="&#x000b1;" align="char">&#x02212;136.54&#x02009;&#x000b1;&#x02009;40.86</td><td char="&#x000b1;" align="char">0.27&#x02009;&#x000b1;&#x02009;0.04</td></tr></tbody></table></table-wrap><table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Parameters used in curve fitting to experimentally obtained endocardial APD<sub>90</sub> restitution data sets</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th><italic>n</italic></th><th><italic>y</italic><sub>0</sub> (ms)</th><th><italic>A</italic> (ms)</th><th><italic>&#x003c4;</italic> (ms)</th><th><italic>&#x003c7;</italic><sup>2</sup></th><th>CDI (ms)</th><th>Maximum gradient</th></tr></thead><tbody><tr><td><italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup></td><td char="." align="char">6</td><td char="&#x000b1;" align="char">104.89&#x02009;&#x000b1;&#x02009;21.81</td><td char="&#x000b1;" align="char">159.31&#x02009;&#x000b1;&#x02009;20.84</td><td char="&#x000b1;" align="char">30.25&#x02009;&#x000b1;&#x02009;2.78</td><td char="." align="char">0.654</td><td char="&#x000b1;" align="char">50.26&#x02009;&#x000b1;&#x02009;9.27</td><td char="&#x000b1;" align="char">1.11&#x02009;&#x000b1;&#x02009;0.21</td></tr><tr><td><italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup>+20&#x000a0;&#x000b5;M nicorandil</td><td char="." align="char">6</td><td char="&#x000b1;" align="char">&#x02212;22.97&#x02009;&#x000b1;&#x02009;6.30</td><td char="&#x000b1;" align="char">86.38&#x02009;&#x000b1;&#x02009;4.45</td><td char="&#x000b1;" align="char">50.87&#x02009;&#x000b1;&#x02009;5.93</td><td char="." align="char">0.152</td><td char="&#x000b1;" align="char">26.94&#x02009;&#x000b1;&#x02009;4.65</td><td char="&#x000b1;" align="char">0.76&#x02009;&#x000b1;&#x02009;0.07</td></tr><tr><td>WT</td><td char="." align="char">6</td><td char="&#x000b1;" align="char">&#x02212;13.81&#x02009;&#x000b1;&#x02009;4.37</td><td char="&#x000b1;" align="char">81.31&#x02009;&#x000b1;&#x02009;2.21</td><td char="&#x000b1;" align="char">63.07&#x02009;&#x000b1;&#x02009;7.50</td><td char="." align="char">0.178</td><td char="&#x000b1;" align="char">16.02&#x02009;&#x000b1;&#x02009;2.73</td><td char="&#x000b1;" align="char">0.69&#x02009;&#x000b1;&#x02009;0.04</td></tr><tr><td>WT+20&#x000a0;&#x000b5;M nicorandil</td><td char="." align="char">6</td><td char="&#x000b1;" align="char">6.89&#x02009;&#x000b1;&#x02009;1.44</td><td char="&#x000b1;" align="char">66.89&#x02009;&#x000b1;&#x02009;1.28</td><td char="&#x000b1;" align="char">80.50&#x02009;&#x000b1;&#x02009;6.61</td><td char="." align="char">0.081</td><td char="&#x000b1;" align="char">&#x02212;14.91&#x02009;&#x000b1;&#x02009;1.75</td><td char="&#x000b1;" align="char">0.54&#x02009;&#x000b1;&#x02009;0.03</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec17"><title>Restitution curves in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> and WT hearts show contrasting critical diastolic intervals and maximum gradients</title><p>The slopes of restitution curves obtained under the different experimental conditions were quantified and summarized in Tables&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> and <xref rid="Tab2" ref-type="table">2</xref>. This analysis showed that, in the absence of nicorandil, <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts possessed steeper gradients of restitution curves than WT hearts as assessed by both their critical diastolic intervals (CDIs) and their maximum gradients. CDI, the DI at which the gradient equals unity [<xref ref-type="bibr" rid="CR45">45</xref>], was calculated from the fitted function. Untreated <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts showed larger epicardial CDIs than WTs, 46.26&#x02009;&#x000b1;&#x02009;6.48 versus 9.76&#x02009;&#x000b1;&#x02009;1.06&#x000a0;ms (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001; <italic>n</italic>&#x02009;=&#x02009;6 in both cases). Similarly, larger CDIs were observed in the endocardium of <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts having a CDI of 50.26&#x02009;&#x000b1;&#x02009;9.27 versus 16.02&#x02009;&#x000b1;&#x02009;2.73&#x000a0;ms in WT hearts (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01; <italic>n</italic>&#x02009;=&#x02009;6 in both cases). We therefore demonstrate larger CDIs in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts compared to WT hearts and confirm this in both epicardium and endocardium.</p><p>Maximum gradients of APD<sub>90</sub> restitution curves were then compared. In the epicardium of <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts, the maximum gradient was 1.32&#x02009;&#x000b1;&#x02009;0.18, significantly larger than in WT hearts in which the maximum gradient was 0.59&#x02009;&#x000b1;&#x02009;0.02 (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01; <italic>n</italic>&#x02009;=&#x02009;6 in both cases). In the endocardium, the maximum gradient was also larger in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts than in WTs hearts, though this did not reach statistical significance, with gradients of 1.11&#x02009;&#x000b1;&#x02009;0.21 versus 0.69&#x02009;&#x000b1;&#x02009;0.04 in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> and WT hearts, respectively (<italic>n</italic>&#x02009;=&#x02009;6 in both cases).</p></sec><sec id="Sec18"><title>Alterations in CDIs and maximum gradients correlate with changes in arrhythmogenic tendencies in both <italic>KCNE1</italic><sup><bold>&#x02212;</bold>/<bold>&#x02212;</bold></sup> and WT hearts</title><p>In view of the observed antiarrhythmic actions of nicorandil in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts, we then quantified the effects of nicorandil (20&#x000a0;&#x000b5;M), the highest concentration at which significant antiarrhythmic effects were observed, upon CDIs and maximum gradients for the first time in any model of JLN. Nicorandil significantly reduced the CDI in the epicardium of <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts (Fig.&#x000a0;<xref rid="Fig10" ref-type="fig">10</xref>a) from 46.26&#x02009;&#x000b1;&#x02009;6.48 to &#x02212;0.15&#x02009;&#x000b1;&#x02009;0.05&#x000a0;ms (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001; <italic>n</italic>&#x02009;=&#x02009;6 in both cases). It had a similar action upon the CDI in the endocardium of <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts, shortening the CDI from 50.26&#x02009;&#x000b1;&#x02009;9.27 to 26.94&#x02009;&#x000b1;&#x02009;4.65 (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05; <italic>n</italic>&#x02009;=&#x02009;6 in both cases). The maximum gradient was also significantly reduced in both the epicardium, from 1.32&#x02009;&#x000b1;&#x02009;0.18 to 0.55&#x02009;&#x000b1;&#x02009;0.04 (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01), and appreciably but not significantly in the endocardium, from 1.11&#x02009;&#x000b1;&#x02009;0.21 to 0.76&#x02009;&#x000b1;&#x02009;0.07 (<italic>P</italic>&#x02009;&#x0003e;&#x02009;0.05) (Fig.&#x000a0;<xref rid="Fig10" ref-type="fig">10</xref>c). In WT hearts, nicorandil reduced the epicardial CDI (Fig.&#x000a0;<xref rid="Fig10" ref-type="fig">10</xref>b), from 9.76&#x02009;&#x000b1;&#x02009;1.06 to &#x02212;136.54&#x02009;&#x000b1;&#x02009;40.86&#x000a0;ms (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05; <italic>n</italic>&#x02009;=&#x02009;6). Similarly, nicorandil reduced the CDI in the endocardium of WT hearts from 16.02&#x02009;&#x000b1;&#x02009;2.73 to &#x02212;14.91&#x02009;&#x000b1;&#x02009;1.75&#x000a0;ms (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001; <italic>n</italic>&#x02009;=&#x02009;6). It also decreased the maximum gradient of restitution curves in WT hearts (Fig. <xref rid="Fig10" ref-type="fig">10</xref>d). This occurred in the epicardium, from 0.59&#x02009;&#x000b1;&#x02009;0.02 to 0.27&#x02009;&#x000b1;&#x02009;0.04 (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001; <italic>n</italic>&#x02009;=&#x02009;6), and in the endocardium, from 0.69&#x02009;&#x000b1;&#x02009;0.04 to 0.54&#x02009;&#x000b1;&#x02009;0.03 (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05; <italic>n</italic>&#x02009;=&#x02009;6) in untreated and nicorandil-treated WT hearts, respectively. <fig id="Fig10"><label>Fig.&#x000a0;10</label><caption><p>CDI (<bold>a</bold> and <bold>b</bold>) and maximum gradients (<bold>c</bold> and <bold>d</bold>) derived from restitution curves from the epicardium and endocardium of <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> (<bold>a</bold> and <bold>c</bold>) and WT (<bold>b</bold> and <bold>d</bold>) hearts perfused with control solution or 20&#x000a0;&#x000b5;M nicorandil (*<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05; **<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01, ***<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001)</p></caption><graphic position="anchor" xlink:href="424_2009_671_Fig10_HTML" id="MO10"/></fig></p><p>Thus, the enhanced arrhythmogenicity observed in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts was associated with steeper epicardial and endocardial restitution curves compared to WT hearts, while reductions in arrhythmogenicity by nicorandil were accompanied by reductions in such gradients.</p></sec></sec><sec id="Sec19" sec-type="discussion"><title>Discussion</title><p>The experiments described in this study characterized arrhythmic properties and their possible mechanisms at the whole organ level by comparing isolated perfused <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> with WT hearts. The primary abnormality in the <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> murine system is a loss-of-function, targeted deletion of the gene encoding the minK K<sup>+</sup> channel accessory &#x003b2;-subunit. In common with patients with the corresponding JLN syndrome [<xref ref-type="bibr" rid="CR20">20</xref>], the <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> mouse is known to possess inner ear defects, manifesting as deafness and shaker/waltzer behavior, attributed to deficient transepithelial K<sup>+</sup> secretion in the stria vascularis and vestibular dark cells of the inner ear. Histological appearances in the inner ears of <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> mice [<xref ref-type="bibr" rid="CR68">68</xref>] were also shown to be similar to those observed in post-mortem inspections of the human condition [<xref ref-type="bibr" rid="CR11">11</xref>]. Previous experiments in patch-clamped neonatal cardiac myocytes, rather than whole heart investigations, had suggested alterations in cardiac electrophysiology involving late as opposed to early (<italic>I</italic><sub>to</sub>) K<sup>+</sup> current in the <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> cardiac system [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. These empirically demonstrated reductions in the rapid component of the delayed rectifier current (<italic>I</italic><sub>Kr</sub>) [<xref ref-type="bibr" rid="CR30">30</xref>] relative to WT and a total absence of the slow component, <italic>I</italic><sub>Ks</sub> [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR30">30</xref>], albeit from relatively low levels of detection in WTs. Correspondingly, mRNA for minK was detectable at low levels in WT but totally absent from <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> myocytes [<xref ref-type="bibr" rid="CR9">9</xref>]. In contrast, early outward currents (<italic>I</italic><sub>to</sub>) remained conserved [<xref ref-type="bibr" rid="CR30">30</xref>] as were mRNA levels [<xref ref-type="bibr" rid="CR9">9</xref>] for the alpha subunit KvLQT1 (which together with minK is responsible for <italic>I</italic><sub>Ks</sub> [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]), K<sub>v</sub>1.5 (the alpha subunit responsible for <italic>I</italic><sub>Kur</sub> [<xref ref-type="bibr" rid="CR70">70</xref>]) and mERG (the murine protein corresponding to the human alpha subunit protein, HERG, that underlies <italic>I</italic><sub>Kr</sub> [<xref ref-type="bibr" rid="CR48">48</xref>]).</p><p>This paper complements those cellular studies. It reports that intact, perfused <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> mouse hearts recapitulated cardiac features of the JLN2 variant of JLN syndrome [<xref ref-type="bibr" rid="CR20">20</xref>] in their enhanced susceptibility to VT. It then related these properties to the presence of triggered activity and to criteria for re-entrant excitation that enabled the detection and separation of underlying re-entrant substrates. We then both empirically tested the efficacy of nicorandil as an antiarrhythmic agent in the <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> murine model and related this to actions on such re-entrant criteria for the first time. In doing so, we empirically tested the idea that arrhythmogenicity could be reduced by the action of nicorandil, which, at the higher concentrations used in this study, has been shown to shorten cardiac APDs in other cardiac preparations (see the &#x0201c;<xref rid="Sec1" ref-type="sec">Introduction</xref>&#x0201d; section) possibly through acting upon K<sup>+</sup> conductance [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR60">60</xref>], independent of external Na<sup>+</sup>, and in the absence of alterations in Ca<sup>2+</sup> currents [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. It has been suggested for use as a potentially antiarrhythmic pharmacological agent in LQTS, supported by preliminary clinical studies in patients with LQT1 [<xref ref-type="bibr" rid="CR58">58</xref>] and familial [<xref ref-type="bibr" rid="CR1">1</xref>] and idiopathic [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR50">50</xref>] LQTS where the genotype had not been determined. Experimental studies in a hypokalaemic murine model [<xref ref-type="bibr" rid="CR26">26</xref>], a genetic murine LQT3 model [<xref ref-type="bibr" rid="CR17">17</xref>], a pharmacological guinea pig LQT1 model [<xref ref-type="bibr" rid="CR76">76</xref>], and pharmacological canine LQT1, LQT2, and LQT3 models are also consistent with potential antiarrhythmic roles for nicorandil [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR57">57</xref>]. However, neither this antiarrhythmic action nor its possible mechanisms at the level of intact hearts have been specifically tested in any system modelling loss-of-function mutations in <italic>KCNE1</italic>, whether obtained through pharmacological or genetic modification or whether in experimental or clinical situations. We used concentrations (10 and 20&#x000a0;&#x000b5;M) comparable to those employed in earlier reports of nicorandil-mediated reductions in repolarization durations or suppressed arrhythmogenesis in other cardiac systems whether at the cellular [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR75">75</xref>], tissue [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR76">76</xref>], or whole organ levels [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR76">76</xref>].</p><p>Our experiments demonstrated both spontaneous and provoked arrhythmogenesis in isolated perfused <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts. They complement earlier reports that demonstrated altered electrocardiographic QT&#x02013;heart rate relationships in intact anesthetized animals compatible with arrhythmogenic consequences [<xref ref-type="bibr" rid="CR9">9</xref>] (but see [<xref ref-type="bibr" rid="CR30">30</xref>]). A further report did not observe provoked arrhythmogenesis on the basis of optical recordings in Langendorff-perfused hearts. However, that study [<xref ref-type="bibr" rid="CR47">47</xref>] adopted left ventricular apical rather than right ventricular stimulation, used longer (200&#x000a0;ms instead of 125&#x000a0;ms) BCLs, employed differing PES or burst stimulus protocols, and used C57Black6 rather than 129/Sv animals. Nevertheless, the arrhythmogenic properties described in the present paper closely agree with previous studies that had employed stimulation protocols and murine strains [<xref ref-type="bibr" rid="CR4">4</xref>] that were comparable both to those used in this study and to those used to explore other murine models [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. These contrasts are consistent with the suggestion that arrhythmogenic propensity may require particularly sensitive provocation techniques for their detection [<xref ref-type="bibr" rid="CR51">51</xref>].</p><p>The present experiments additionally applied a set of criteria previously developed in the murine system [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR64">64</xref>]. They were applied in both <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> and WT hearts, in the absence and presence of nicorandil. This application yielded parameters that were used to detect the presence or absence of both <italic>spatial</italic> re-entrant substrate, reflected in &#x02206;APD<sub>90</sub> and critical intervals for local re-excitation, and <italic>temporal</italic> re-entrant substrate, reflected in APD<sub>90</sub> alternans and APD<sub>90</sub> restitution properties.</p><p>Firstly, we demonstrated that intrinsically beating <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup>, but not WT hearts, showed spontaneous, nicorandil-sensitive triggered activity that was accompanied by longer runs of spontaneous VT. These had not been sought in previous reports [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR47">47</xref>] which had studied electrocardiographic records, bipolar electrograms, or optical traces, rather than the MAP records used in this study. Nevertheless, these observations agree with and extend a recent description of MAP records which showed spontaneous nifedipine-sensitive abnormalities of repolarization [<xref ref-type="bibr" rid="CR66">66</xref>]. The present studies go on to demonstrate that nicorandil suppressed both the triggered activity and the spontaneous VT.</p><p>Secondly, in contrast to WT, <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts showed evidence for abnormal <italic>spatial</italic> patterns of repolarization. This took the form of increased epicardial, though conserved endocardial, APD<sub>90</sub>s. This would in turn perturb transmural gradients of repolarization by resulting in reduced or even negative &#x02206;APD<sub>90</sub>s. These findings could be obtained from the measurements of both endocardial and epicardial MAP, thereby adding to reports that were confined to either electrocardiographic or optical epicardial recordings [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. These results in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts complement findings in other arrhythmogenic murine systems modeling human LQT3 [<xref ref-type="bibr" rid="CR64">64</xref>] and acquired hypokalaemic LQTS [<xref ref-type="bibr" rid="CR25">25</xref>] which also show prolonged epicardial relative to endocardial APD<sub>90</sub>. Altered spatial patterns of repolarization have also been demonstrated in pharmacological models of LQTS involving the arterially-perfused canine wedge [<xref ref-type="bibr" rid="CR3">3</xref>]. Such alterations may contribute to re-entrant arrhythmogenesis in view of the relatively short distance across the thickness of the ventricular free wall [<xref ref-type="bibr" rid="CR3">3</xref>]. We went on to demonstrate that nicorandil increased &#x02206;APD<sub>90</sub> by reducing the epicardial APD<sub>90</sub> while conserving the endocardial APD<sub>90</sub> not only in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> but also in WT hearts. It thus corrected the alteration in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts in the direction of and consequently approximating WT values that had been observed in the absence of nicorandil. Such region-dependent actions of nicorandil upon epicardial rather than endocardial APD<sub>90</sub> have been observed in a canine ischaemic model [<xref ref-type="bibr" rid="CR32">32</xref>] as well as in hypokalaemic murine hearts [<xref ref-type="bibr" rid="CR26">26</xref>].</p><p>Thirdly, <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts demonstrated larger local critical intervals for re-excitation than WT hearts. This paralleled their enhanced tendencies to spontaneous and provoked arrhythmogenesis. Such intervals were derived from the difference between APD<sub>90</sub> and refractory period and have also been correlated with arrhythmogenic propensity in hypokalaemic murine hearts [<xref ref-type="bibr" rid="CR44">44</xref>]. Treatment with nicorandil significantly reduced these critical intervals in both <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> and WT hearts in parallel with reductions in arrhythmic tendency in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts.</p><p>Fourthly, both <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> and WT hearts demonstrated enhanced tendencies to APD<sub>90</sub> alternans as derived from differences in successive odd and even APD<sub>90</sub> values with decreasing BCL. However, such alternans was consistently greater in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> than in WT hearts in both epicardium and endocardium. Such trends have also been observed in murine models for LQT3 and hypokalaemic acquired LQTS [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. These findings also complement a previous electrocardiographic study that reported a development of T wave alternans (TWA) during isoproterenol-mediated increases in heart rate. The latter study did not observe differences between WT and <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts, but had studied relatively small numbers of anesthetized, intact mutant (two mice) and WT preparations (three mice) [<xref ref-type="bibr" rid="CR9">9</xref>]. Furthermore, the properties shown by our isolated denervated cardiac preparations agree with and add to previous findings obtained under comparable conditions but confined to a single basic cycle length [<xref ref-type="bibr" rid="CR66">66</xref>]. Previous analysis of human action potential waveforms using MAP electrodes has directly correlated APD alternans with TWA in LQTS [<xref ref-type="bibr" rid="CR59">59</xref>]. In general, APD alternans is thought to underlie the TWA that has been observed in clinical electrocardiographic traces [<xref ref-type="bibr" rid="CR34">34</xref>]. The latter in turn has been associated with enhanced arrhythmogenic propensity not only in LQTS [<xref ref-type="bibr" rid="CR54">54</xref>] but also in a wide variety of other arrhythmic settings, including ischaemia, acidosis, and pharmacological agents (reviewed in [<xref ref-type="bibr" rid="CR34">34</xref>]). Our results go on to additionally demonstrate that nicorandil reduced APD alternans in <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts to levels similar to WT hearts in both epicardium and endocardium.</p><p>Fifthly, application of a dynamic pacing protocol [<xref ref-type="bibr" rid="CR29">29</xref>] to <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts permitted quantification of MAP waveforms in the steady-state achieved following introduction of a range of given BCLs. This approach successfully demonstrated that both epicardial and endocardial APD<sub>90</sub> restitution curves from <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts showed greater slopes than did WT hearts in parallel with their arrhythmogenic tendencies. Establishing that such properties exist in isolated hearts free of autonomic innervation, as performed in this study, also complements a previous electrocardiographic study that reported abnormal adaptation of QT interval to heart rate in intact anesthetized <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> mice [<xref ref-type="bibr" rid="CR9">9</xref>]. However, this could not examine the relationship between APD<sub>90</sub> and DI. Our findings contrast with measurements that had been obtained using extrasystolic stimuli rather than exploring a range of BCLs using a dynamic pacing protocol [<xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR66">66</xref>]. Nevertheless, our results are likely to provide closer representations of APD since our use of contact MAP electrodes rather than optical measurements permitted both epicardial and endocardial recordings and yielded APD<sub>90</sub> rather than APD<sub>75</sub> values. This enabled relationships between APD<sub>90</sub> and DI rather than APD<sub>75</sub> and BCL to be investigated. This in turn permitted the graphical analysis introduced by Nolasco and Dahlens that permitted us to establish whether there existed a CDI at which APD<sub>90</sub> varied with DI in a manner compatible with re-entrant arrhythmogenesis [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR72">72</xref>]. The present studies consequently add to previous demonstrations of temporal re-entrant substrate in other arrhythmogenic murine heart models for LQT3 and Brugada syndrome [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR46">46</xref>] and hypokalaemic VT [<xref ref-type="bibr" rid="CR45">45</xref>]. Our results also demonstrated that nicorandil treatment reduced these gradients in both <italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> and WT hearts in parallel with its reduction of arrhythmogenic tendency.</p><p><italic>KCNE1</italic><sup>&#x02212;/&#x02212;</sup> hearts thus provided us with a valuable arrhythmogenic model exhibiting not only spontaneous but also PES-induced VT. They showed accompanying spontaneous triggered activity as well as measurable spatial and temporal heterogeneities in MAP waveform that could potentially underlie such arrhythmogenic tendencies. The present experiments went on to confirm such a hypothesis by demonstrating that an introduction of nicorandil produced a parallel abolition of all these properties. This was consistent with a participation of both triggered activity and spatial and temporal re-entrant substrate in the properties observed.</p></sec></body><back><ack><title>Acknowledgements</title><p>Funding was provided by the Wellcome Trust, Medical Research Council, British Heart Foundation, Helen Kirkland Trust, and Papworth Hospital, UK. SSH was supported by a Medical Research Council Capacity Building Studentship. MJK acknowledges the generous support of the Avrith Fund. Sandeep S. Hothi and Glyn Thomas have contributed equally to this work.</p><p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aizawa</surname><given-names>Y</given-names></name><name><surname>Uchiyama</surname><given-names>H</given-names></name><name><surname>Yamaura</surname><given-names>M</given-names></name><name><surname>Nakayama</surname><given-names>T</given-names></name><name><surname>Arita</surname><given-names>M</given-names></name></person-group><article-title>Effects of the ATP-sensitive K channel opener nicorandil on the QT interval and the effective refractory period in patients with congenital long QT syndrome</article-title><source>J Electrocardiol</source><year>1998</year><volume>31</volume><fpage>117</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1016/S0022-0736(98)90042-5</pub-id></citation><citation citation-type="display-unstructured">Aizawa Y, Uchiyama H, Yamaura M, Nakayama T, Arita M (1998) Effects of the ATP-sensitive K channel opener nicorandil on the QT interval and the effective refractory period in patients with congenital long QT syndrome. J Electrocardiol 31:117&#x02013;123 <pub-id pub-id-type="pmid">9588657</pub-id></citation></ref><ref id="CR2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Antzelevitch</surname><given-names>C</given-names></name></person-group><article-title>Brugada syndrome</article-title><source>Pacing Clin Electrophysiol</source><year>2006</year><volume>29</volume><fpage>1130</fpage><lpage>1159</lpage><pub-id pub-id-type="doi">10.1111/j.1540-8159.2006.00507.x</pub-id></citation><citation citation-type="display-unstructured">Antzelevitch C (2006) Brugada syndrome. Pacing Clin Electrophysiol 29:1130&#x02013;1159 <pub-id pub-id-type="pmid">17038146</pub-id></citation></ref><ref id="CR3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Antzelevitch</surname><given-names>C</given-names></name><name><surname>Oliva</surname><given-names>A</given-names></name></person-group><article-title>Amplification of spatial dispersion of repolarization underlies sudden cardiac death associated with catecholaminergic polymorphic VT, long QT, short QT and Brugada syndromes</article-title><source>J Intern Med</source><year>2006</year><volume>259</volume><fpage>48</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2796.2005.01587.x</pub-id></citation><citation citation-type="display-unstructured">Antzelevitch C, Oliva A (2006) Amplification of spatial dispersion of repolarization underlies sudden cardiac death associated with catecholaminergic polymorphic VT, long QT, short QT and Brugada syndromes. J Intern Med 259:48&#x02013;58 <pub-id pub-id-type="pmid">16336513</pub-id></citation></ref><ref id="CR4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balasubramaniam</surname><given-names>R</given-names></name><name><surname>Grace</surname><given-names>AA</given-names></name><name><surname>Saumarez</surname><given-names>RC</given-names></name><name><surname>Vandenberg</surname><given-names>JI</given-names></name><name><surname>Huang</surname><given-names>CLH</given-names></name></person-group><article-title>Electrogram prolongation and nifedipine-suppressible ventricular arrhythmias in mice following targeted disruption of <italic>KCNE1</italic></article-title><source>J Physiol</source><year>2003</year><volume>552</volume><fpage>535</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2003.048249</pub-id></citation><citation citation-type="display-unstructured">Balasubramaniam R, Grace AA, Saumarez RC, Vandenberg JI, Huang CLH (2003) Electrogram prolongation and nifedipine-suppressible ventricular arrhythmias in mice following targeted disruption of KCNE1. J Physiol 552:535&#x02013;546 <pub-id pub-id-type="pmid">14561835</pub-id></citation></ref><ref id="CR5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barhanin</surname><given-names>J</given-names></name><name><surname>Lesage</surname><given-names>F</given-names></name><name><surname>Guillemare</surname><given-names>E</given-names></name><name><surname>Fink</surname><given-names>M</given-names></name><name><surname>Lazdunski</surname><given-names>M</given-names></name><name><surname>Romey</surname><given-names>G</given-names></name></person-group><article-title>KvLQT1 and IsK (minK) proteins associate to form the <italic>I</italic><sub>KS</sub> cardiac potassium current</article-title><source>Nature</source><year>1996</year><volume>384</volume><fpage>78</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1038/384078a0</pub-id></citation><citation citation-type="display-unstructured">Barhanin J, Lesage F, Guillemare E, Fink M, Lazdunski M, Romey G (1996) KvLQT1 and IsK (minK) proteins associate to form the IKS cardiac potassium current. Nature 384:78&#x02013;80 <pub-id pub-id-type="pmid">8900282</pub-id></citation></ref><ref id="CR6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>C-E</given-names></name><name><surname>Roden</surname><given-names>DM</given-names></name></person-group><article-title>The long QT syndromes: genetic basis and clinical implications</article-title><source>J Am Coll Cardiol</source><year>2000</year><volume>36</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1016/S0735-1097(00)00716-6</pub-id></citation><citation citation-type="display-unstructured">Chiang C-E, Roden DM (2000) The long QT syndromes: genetic basis and clinical implications. J Am Coll Cardiol 36:1&#x02013;12 <pub-id pub-id-type="pmid">10898405</pub-id></citation></ref><ref id="CR7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chinushi</surname><given-names>M</given-names></name><name><surname>Kasai</surname><given-names>H</given-names></name><name><surname>Tagawa</surname><given-names>M</given-names></name><name><surname>Washizuka</surname><given-names>T</given-names></name><name><surname>Hosaka</surname><given-names>Y</given-names></name><name><surname>Chinushi</surname><given-names>Y</given-names></name><name><surname>Aizawa</surname><given-names>Y</given-names></name></person-group><article-title>Triggers of ventricular tachyarrhythmias and therapeutic effects of nicorandil in canine models of LQT2 and LQT3 syndromes</article-title><source>J Am Coll Cardiol</source><year>2002</year><volume>40</volume><fpage>555</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1016/S0735-1097(02)01975-7</pub-id></citation><citation citation-type="display-unstructured">Chinushi M, Kasai H, Tagawa M, Washizuka T, Hosaka Y, Chinushi Y, Aizawa Y (2002) Triggers of ventricular tachyarrhythmias and therapeutic effects of nicorandil in canine models of LQT2 and LQT3 syndromes. J Am Coll Cardiol 40:555&#x02013;562 <pub-id pub-id-type="pmid">12142125</pub-id></citation></ref><ref id="CR8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crotti</surname><given-names>L</given-names></name><name><surname>Celano</surname><given-names>G</given-names></name><name><surname>Dagradi</surname><given-names>F</given-names></name><name><surname>Schwartz</surname><given-names>P</given-names></name></person-group><article-title>Congenital long QT syndrome</article-title><source>Orphanet J Rare Dis</source><year>2008</year><volume>3</volume><fpage>18</fpage><pub-id pub-id-type="doi">10.1186/1750-1172-3-18</pub-id></citation><citation citation-type="display-unstructured">Crotti L, Celano G, Dagradi F, Schwartz P (2008) Congenital long QT syndrome. Orphanet J Rare Dis 3:18 <pub-id pub-id-type="pmid">18606002</pub-id></citation></ref><ref id="CR9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Drici</surname><given-names>M-D</given-names></name><name><surname>Arrighi</surname><given-names>I</given-names></name><name><surname>Chouabe</surname><given-names>C</given-names></name><name><surname>Mann</surname><given-names>JR</given-names></name><name><surname>Lazdunski</surname><given-names>M</given-names></name><name><surname>Romey</surname><given-names>G</given-names></name><name><surname>Barhanin</surname><given-names>J</given-names></name></person-group><article-title>Involvement of IsK-associated K<sup>+</sup> channel in heart rate control of repolarization in a murine engineered model of Jervell and Lange-Nielsen syndrome</article-title><source>Circ Res</source><year>1998</year><volume>83</volume><fpage>95</fpage><lpage>102</lpage></citation><citation citation-type="display-unstructured">Drici M-D, Arrighi I, Chouabe C, Mann JR, Lazdunski M, Romey G, Barhanin J (1998) Involvement of IsK-associated K+ channel in heart rate control of repolarization in a murine engineered model of Jervell and Lange-Nielsen syndrome. Circ Res 83:95&#x02013;102 <pub-id pub-id-type="pmid">9670922</pub-id></citation></ref><ref id="CR10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fraser</surname><given-names>GR</given-names></name><name><surname>Froggatt</surname><given-names>P</given-names></name><name><surname>James</surname><given-names>TN</given-names></name></person-group><article-title>Congenital deafness associated with electrocardiographic abnormalities, fainting attacks and sudden death: a recessive syndrome</article-title><source>Q J Med</source><year>1964</year><volume>33</volume><fpage>361</fpage><lpage>385</lpage></citation><citation citation-type="display-unstructured">Fraser GR, Froggatt P, James TN (1964) Congenital deafness associated with electrocardiographic abnormalities, fainting attacks and sudden death: a recessive syndrome. Q J Med 33:361&#x02013;385 <pub-id pub-id-type="pmid">14176667</pub-id></citation></ref><ref id="CR11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Friedmann</surname><given-names>I</given-names></name><name><surname>Fraser</surname><given-names>GR</given-names></name><name><surname>Froggatt</surname><given-names>P</given-names></name></person-group><article-title>Pathology of the ear in the cardio-auditory syndrome of Jervell and Lange-Nielsen (recessive deafness with electrocardiographic abnormalities)</article-title><source>J Laryngol Otol</source><year>1966</year><volume>80</volume><fpage>451</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1017/S002221510006552X</pub-id></citation><citation citation-type="display-unstructured">Friedmann I, Fraser GR, Froggatt P (1966) Pathology of the ear in the cardio-auditory syndrome of Jervell and Lange-Nielsen (recessive deafness with electrocardiographic abnormalities). J Laryngol Otol 80:451&#x02013;470 <pub-id pub-id-type="pmid">5295857</pub-id></citation></ref><ref id="CR12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fujimoto</surname><given-names>Y</given-names></name><name><surname>Kusano</surname><given-names>KF</given-names></name><name><surname>Morita</surname><given-names>H</given-names></name><name><surname>Hong</surname><given-names>K</given-names></name><name><surname>Yamanari</surname><given-names>H</given-names></name><name><surname>Ohe</surname><given-names>T</given-names></name></person-group><article-title>Nicorandil attenuates both temporal and spatial repolarization alternans</article-title><source>J Electrocardiology</source><year>2000</year><volume>33</volume><fpage>269</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1054/jelc.2000.8398</pub-id></citation><citation citation-type="display-unstructured">Fujimoto Y, Kusano KF, Morita H, Hong K, Yamanari H, Ohe T (2000) Nicorandil attenuates both temporal and spatial repolarization alternans. J Electrocardiology 33:269&#x02013;277 </citation></ref><ref id="CR13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fujimoto</surname><given-names>Y</given-names></name><name><surname>Morita</surname><given-names>H</given-names></name><name><surname>Fukushima</surname><given-names>KK</given-names></name><name><surname>Ohe</surname><given-names>T</given-names></name></person-group><article-title>Nicorandil abolished repolarisation alternans in a patient with idiopathic long QT syndrome</article-title><source>Heart</source><year>1999</year><volume>82</volume><fpage>e8</fpage></citation><citation citation-type="display-unstructured">Fujimoto Y, Morita H, Fukushima KK, Ohe T (1999) Nicorandil abolished repolarisation alternans in a patient with idiopathic long QT syndrome. Heart 82:e8 <pub-id pub-id-type="pmid">10525528</pub-id></citation></ref><ref id="CR14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Head</surname><given-names>CE</given-names></name><name><surname>Balasubramaniam</surname><given-names>R</given-names></name><name><surname>Thomas</surname><given-names>G</given-names></name><name><surname>Goddard</surname><given-names>CA</given-names></name><name><surname>Lei</surname><given-names>M</given-names></name><name><surname>Colledge</surname><given-names>WH</given-names></name><name><surname>Grace</surname><given-names>AA</given-names></name><name><surname>Huang</surname><given-names>CL</given-names></name></person-group><article-title>Paced electrogram fractionation analysis of arrhythmogenic tendency in &#x02206;KPQ <italic>Scn5a</italic> mice</article-title><source>J Cardiovasc Electrophysiol</source><year>2005</year><volume>16</volume><fpage>1329</fpage><lpage>1340</lpage></citation><citation citation-type="display-unstructured">Head CE, Balasubramaniam R, Thomas G, Goddard CA, Lei M, Colledge WH, Grace AA, Huang CL (2005) Paced electrogram fractionation analysis of arrhythmogenic tendency in &#x02206;KPQ Scn5a mice. J Cardiovasc Electrophysiol 16:1329&#x02013;1340 <pub-id pub-id-type="pmid">16403066</pub-id></citation></ref><ref id="CR15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hiraoka</surname><given-names>M</given-names></name><name><surname>Fan</surname><given-names>Z</given-names></name></person-group><article-title>Activation of ATP-sensitive outward K<sup>+</sup> current by nicorandil (2-nicotinamidoethyl nitrate) in isolated ventricular myocytes</article-title><source>J Pharmacol Exp Ther</source><year>1989</year><volume>250</volume><fpage>278</fpage><lpage>285</lpage></citation><citation citation-type="display-unstructured">Hiraoka M, Fan Z (1989) Activation of ATP-sensitive outward K+ current by nicorandil (2-nicotinamidoethyl nitrate) in isolated ventricular myocytes. J Pharmacol Exp Ther 250:278&#x02013;285 <pub-id pub-id-type="pmid">2526215</pub-id></citation></ref><ref id="CR16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hothi</surname><given-names>S</given-names></name><name><surname>Gurung</surname><given-names>I</given-names></name><name><surname>Heathcote</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Booth</surname><given-names>S</given-names></name><name><surname>Skepper</surname><given-names>J</given-names></name><name><surname>Grace</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>C</given-names></name></person-group><article-title>Epac activation, altered calcium homeostasis and ventricular arrhythmogenesis in the murine heart</article-title><source>Pfl&#x000fc;gers Archiv</source><year>2008</year><volume>457</volume><fpage>253</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1007/s00424-008-0508-3</pub-id></citation><citation citation-type="display-unstructured">Hothi S, Gurung I, Heathcote J, Zhang Y, Booth S, Skepper J, Grace A, Huang C (2008) Epac activation, altered calcium homeostasis and ventricular arrhythmogenesis in the murine heart. Pfl&#x000fc;gers Archiv 457:253&#x02013;270 <pub-id pub-id-type="pmid">18600344</pub-id></citation></ref><ref id="CR17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hothi</surname><given-names>SS</given-names></name><name><surname>Booth</surname><given-names>SW</given-names></name><name><surname>Sabir</surname><given-names>IN</given-names></name><name><surname>Killeen</surname><given-names>MJ</given-names></name><name><surname>Simpson</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Grace</surname><given-names>AA</given-names></name><name><surname>Huang</surname><given-names>CLH</given-names></name></person-group><article-title>Arrhythmogenic substrate and its modification by nicorandil in a murine model of long QT type 3 syndrome</article-title><source>Prog Biophys Mol Biol</source><year>2009</year><volume>98</volume><fpage>267</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1016/j.pbiomolbio.2009.01.006</pub-id></citation><citation citation-type="display-unstructured">Hothi SS, Booth SW, Sabir IN, Killeen MJ, Simpson F, Zhang Y, Grace AA, Huang CLH (2009) Arrhythmogenic substrate and its modification by nicorandil in a murine model of long QT type 3 syndrome. Prog Biophys Mol Biol 98:267&#x02013;280. doi:10.1016/j.pbiomolbio.2009.01.006 <pub-id pub-id-type="pmid">19351517</pub-id></citation></ref><ref id="CR18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Imanishi</surname><given-names>S</given-names></name><name><surname>Arita</surname><given-names>M</given-names></name><name><surname>Kiyosue</surname><given-names>T</given-names></name><name><surname>Aomine</surname><given-names>M</given-names></name></person-group><article-title>Effects of SG-75 (nicorandil) on electrical activity of canine cardiac Purkinje fibers: possible increase in potassium conductance</article-title><source>J Pharmacol Exp Ther</source><year>1983</year><volume>225</volume><fpage>198</fpage><lpage>205</lpage></citation><citation citation-type="display-unstructured">Imanishi S, Arita M, Kiyosue T, Aomine M (1983) Effects of SG-75 (nicorandil) on electrical activity of canine cardiac Purkinje fibers: possible increase in potassium conductance. J Pharmacol Exp Ther 225:198&#x02013;205 <pub-id pub-id-type="pmid">6300374</pub-id></citation></ref><ref id="CR19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>January</surname><given-names>CT</given-names></name><name><surname>Fozzard</surname><given-names>HA</given-names></name></person-group><article-title>Delayed afterdepolarizations in heart muscle: mechanisms and relevance</article-title><source>Pharmacol Rev</source><year>1988</year><volume>40</volume><fpage>219</fpage><lpage>227</lpage></citation><citation citation-type="display-unstructured">January CT, Fozzard HA (1988) Delayed afterdepolarizations in heart muscle: mechanisms and relevance. Pharmacol Rev 40:219&#x02013;227 <pub-id pub-id-type="pmid">3065793</pub-id></citation></ref><ref id="CR20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jervell</surname><given-names>A</given-names></name><name><surname>Lange-Nielsen</surname><given-names>F</given-names></name></person-group><article-title>Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval, and sudden death</article-title><source>Am Heart J</source><year>1957</year><volume>54</volume><fpage>59</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1016/0002-8703(57)90079-0</pub-id></citation><citation citation-type="display-unstructured">Jervell A, Lange-Nielsen F (1957) Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval, and sudden death. Am Heart J 54:59&#x02013;68 <pub-id pub-id-type="pmid">13435203</pub-id></citation></ref><ref id="CR21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jespersen</surname><given-names>T</given-names></name><name><surname>Grunnet</surname><given-names>M</given-names></name><name><surname>Olesen</surname><given-names>S-P</given-names></name></person-group><article-title>The KCNQ1 potassium channel: from gene to physiological function</article-title><source>Physiology</source><year>2005</year><volume>20</volume><fpage>408</fpage><lpage>416</lpage><pub-id pub-id-type="doi">10.1152/physiol.00031.2005</pub-id></citation><citation citation-type="display-unstructured">Jespersen T, Grunnet M, Olesen S-P (2005) The KCNQ1 potassium channel: from gene to physiological function. Physiology 20:408&#x02013;416 <pub-id pub-id-type="pmid">16287990</pub-id></citation></ref><ref id="CR22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kakei</surname><given-names>M</given-names></name><name><surname>Yoshinaga</surname><given-names>M</given-names></name><name><surname>Saito</surname><given-names>K</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name></person-group><article-title>The potassium current activated by 2-nicotinamidoethyl nitrate (nicorandil) in single ventricular cells of guinea pigs</article-title><source>Proc R Soc Lond B Biol Sci</source><year>1986</year><volume>229</volume><fpage>331</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1098/rspb.1986.0089</pub-id></citation><citation citation-type="display-unstructured">Kakei M, Yoshinaga M, Saito K, Tanaka H (1986) The potassium current activated by 2-nicotinamidoethyl nitrate (nicorandil) in single ventricular cells of guinea pigs. Proc R Soc Lond B Biol Sci 229:331&#x02013;343 <pub-id pub-id-type="pmid">2434957</pub-id></citation></ref><ref id="CR23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Killeen</surname><given-names>MJ</given-names></name><name><surname>Gurung</surname><given-names>IS</given-names></name><name><surname>Thomas</surname><given-names>G</given-names></name><name><surname>Stokoe</surname><given-names>KS</given-names></name><name><surname>Grace</surname><given-names>AA</given-names></name><name><surname>Huang</surname><given-names>CLH</given-names></name></person-group><article-title>Separation of early afterdepolarizations from arrhythmogenic substrate in the isolated perfused hypokalaemic murine heart through modifiers of calcium homeostasis</article-title><source>Acta Physiol (Oxf)</source><year>2007</year><volume>191</volume><fpage>43</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1111/j.1748-1716.2007.01715.x</pub-id></citation><citation citation-type="display-unstructured">Killeen MJ, Gurung IS, Thomas G, Stokoe KS, Grace AA, Huang CLH (2007) Separation of early afterdepolarizations from arrhythmogenic substrate in the isolated perfused hypokalaemic murine heart through modifiers of calcium homeostasis. Acta Physiol (Oxf) 191:43&#x02013;58 <pub-id pub-id-type="pmid">17524066</pub-id></citation></ref><ref id="CR24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Killeen</surname><given-names>MJ</given-names></name><name><surname>Sabir</surname><given-names>IN</given-names></name><name><surname>Grace</surname><given-names>AA</given-names></name><name><surname>Huang</surname><given-names>CLH</given-names></name></person-group><article-title>Dispersions of repolarization and ventricular arrhythmogenesis: Lessons from animal models</article-title><source>Prog Biophys Mol Biol</source><year>2009</year><volume>98</volume><fpage>219</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1016/j.pbiomolbio.2008.10.008</pub-id></citation><citation citation-type="display-unstructured">Killeen MJ, Sabir IN, Grace AA, Huang CLH (2009) Dispersions of repolarization and ventricular arrhythmogenesis: Lessons from animal models. Prog Biophys Mol Biol 98:219&#x02013;229. doi:10.1016/j.pbiomolbio.2008.1010.1008 <pub-id pub-id-type="pmid">19027779</pub-id></citation></ref><ref id="CR25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Killeen</surname><given-names>MJ</given-names></name><name><surname>Thomas</surname><given-names>G</given-names></name><name><surname>Gurung</surname><given-names>IS</given-names></name><name><surname>Goddard</surname><given-names>CA</given-names></name><name><surname>Fraser</surname><given-names>JA</given-names></name><name><surname>Mahaut-Smith</surname><given-names>MP</given-names></name><name><surname>Colledge</surname><given-names>WH</given-names></name><name><surname>Grace</surname><given-names>AA</given-names></name><name><surname>Huang</surname><given-names>CLH</given-names></name></person-group><article-title>Arrhythmogenic mechanisms in the isolated perfused hypokalaemic murine heart</article-title><source>Acta Physiol (Oxf)</source><year>2007</year><volume>189</volume><fpage>33</fpage><lpage>46</lpage></citation><citation citation-type="display-unstructured">Killeen MJ, Thomas G, Gurung IS, Goddard CA, Fraser JA, Mahaut-Smith MP, Colledge WH, Grace AA, Huang CLH (2007) Arrhythmogenic mechanisms in the isolated perfused hypokalaemic murine heart. Acta Physiol (Oxf) 189:33&#x02013;46 <pub-id pub-id-type="pmid">17280555</pub-id></citation></ref><ref id="CR26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Killeen</surname><given-names>MJ</given-names></name><name><surname>Thomas</surname><given-names>G</given-names></name><name><surname>Olesen</surname><given-names>SP</given-names></name><name><surname>Demnitz</surname><given-names>J</given-names></name><name><surname>Stokoe</surname><given-names>KS</given-names></name><name><surname>Grace</surname><given-names>AA</given-names></name><name><surname>Huang</surname><given-names>CLH</given-names></name></person-group><article-title>Effects of potassium channel openers in the isolated perfused hypokalaemic murine heart</article-title><source>Acta Physiol (Oxf)</source><year>2008</year><volume>193</volume><fpage>25</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1111/j.1748-1716.2007.01773.x</pub-id></citation><citation citation-type="display-unstructured">Killeen MJ, Thomas G, Olesen SP, Demnitz J, Stokoe KS, Grace AA, Huang CLH (2008) Effects of potassium channel openers in the isolated perfused hypokalaemic murine heart. Acta Physiol (Oxf) 193:25&#x02013;36 <pub-id pub-id-type="pmid">18005217</pub-id></citation></ref><ref id="CR27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Killeen</surname><given-names>MJ</given-names></name><name><surname>Thomas</surname><given-names>G</given-names></name><name><surname>Sabir</surname><given-names>IN</given-names></name><name><surname>Grace</surname><given-names>AA</given-names></name><name><surname>Huang</surname><given-names>CL</given-names></name></person-group><article-title>Mouse models of human arrhythmia syndromes</article-title><source>Acta Physiol (Oxf)</source><year>2008</year><volume>192</volume><fpage>455</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1111/j.1748-1716.2007.01822.x</pub-id></citation><citation citation-type="display-unstructured">Killeen MJ, Thomas G, Sabir IN, Grace AA, Huang CL (2008) Mouse models of human arrhythmia syndromes. Acta Physiol (Oxf) 192:455&#x02013;469 <pub-id pub-id-type="pmid">18045245</pub-id></citation></ref><ref id="CR28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Knollmann</surname><given-names>BC</given-names></name><name><surname>Katchman</surname><given-names>AN</given-names></name><name><surname>Franz</surname><given-names>MR</given-names></name></person-group><article-title>Monophasic action potential recordings from intact mouse heart: validation, regional heterogeneity, and relation to refractoriness</article-title><source>J Cardiovasc Electrophysiol</source><year>2001</year><volume>12</volume><fpage>1286</fpage><lpage>1294</lpage><pub-id pub-id-type="doi">10.1046/j.1540-8167.2001.01286.x</pub-id></citation><citation citation-type="display-unstructured">Knollmann BC, Katchman AN, Franz MR (2001) Monophasic action potential recordings from intact mouse heart: validation, regional heterogeneity, and relation to refractoriness. J Cardiovasc Electrophysiol 12:1286&#x02013;1294 <pub-id pub-id-type="pmid">11761418</pub-id></citation></ref><ref id="CR29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koller</surname><given-names>ML</given-names></name><name><surname>Riccio</surname><given-names>ML</given-names></name><name><surname>Gilmour</surname><given-names>RF</given-names></name></person-group><article-title>Dynamic restitution of action potential duration during electrical alternans and ventricular fibrillation</article-title><source>Am J Physiol</source><year>1998</year><volume>275</volume><fpage>H1635</fpage><lpage>H1642</lpage></citation><citation citation-type="display-unstructured">Koller ML, Riccio ML, Gilmour RF (1998) Dynamic restitution of action potential duration during electrical alternans and ventricular fibrillation. Am J Physiol 275:H1635&#x02013;H1642 <pub-id pub-id-type="pmid">9815071</pub-id></citation></ref><ref id="CR30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kupershmidt</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>T</given-names></name><name><surname>Anderson</surname><given-names>ME</given-names></name><name><surname>Wessels</surname><given-names>A</given-names></name><name><surname>Niswender</surname><given-names>KD</given-names></name><name><surname>Magnuson</surname><given-names>MA</given-names></name><name><surname>Roden</surname><given-names>DM</given-names></name></person-group><article-title>Replacement by homologous recombination of the minK gene with lacZ reveals restriction of minK expression to the mouse cardiac conduction system</article-title><source>Circ Res</source><year>1999</year><volume>84</volume><fpage>146</fpage><lpage>152</lpage></citation><citation citation-type="display-unstructured">Kupershmidt S, Yang T, Anderson ME, Wessels A, Niswender KD, Magnuson MA, Roden DM (1999) Replacement by homologous recombination of the minK gene with lacZ reveals restriction of minK expression to the mouse cardiac conduction system. Circ Res 84:146&#x02013;152 <pub-id pub-id-type="pmid">9933245</pub-id></citation></ref><ref id="CR31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lathrop</surname><given-names>DA</given-names></name><name><surname>Nanasi</surname><given-names>PP</given-names></name><name><surname>Varro</surname><given-names>A</given-names></name></person-group><article-title>In vitro cardiac models of dog Purkinje fibre triggered and spontaneous electrical activity: effects of nicorandil</article-title><source>Br J Pharmacol</source><year>1990</year><volume>99</volume><fpage>119</fpage><lpage>123</lpage></citation><citation citation-type="display-unstructured">Lathrop DA, Nanasi PP, Varro A (1990) In vitro cardiac models of dog Purkinje fibre triggered and spontaneous electrical activity: effects of nicorandil. Br J Pharmacol 99:119&#x02013;123 <pub-id pub-id-type="pmid">2139585</pub-id></citation></ref><ref id="CR32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miyoshi</surname><given-names>S</given-names></name><name><surname>Miyazaki</surname><given-names>T</given-names></name><name><surname>Moritani</surname><given-names>K</given-names></name><name><surname>Ogawa</surname><given-names>S</given-names></name></person-group><article-title>Different responses of epicardium and endocardium to KATP channel modulators during regional ischemia</article-title><source>Am J Physiol Heart Circ Physiol</source><year>1996</year><volume>271</volume><fpage>H140</fpage><lpage>H147</lpage></citation><citation citation-type="display-unstructured">Miyoshi S, Miyazaki T, Moritani K, Ogawa S (1996) Different responses of epicardium and endocardium to KATP channel modulators during regional ischemia. Am J Physiol Heart Circ Physiol 271:H140&#x02013;H147 </citation></ref><ref id="CR33"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moss</surname><given-names>AJ</given-names></name><name><surname>Goldenberg</surname><given-names>I</given-names></name></person-group><article-title>Importance of knowing the genotype and the specific mutation when managing patients with long-QT syndrome</article-title><source>Circ Arrhythmia Electrophysiol</source><year>2008</year><volume>1</volume><fpage>219</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1161/CIRCEP.108.796599</pub-id></citation><citation citation-type="display-unstructured">Moss AJ, Goldenberg I (2008) Importance of knowing the genotype and the specific mutation when managing patients with long-QT syndrome. Circ Arrhythmia Electrophysiol 1:219&#x02013;226 </citation></ref><ref id="CR34"><label>34.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Myles</surname><given-names>RC</given-names></name><name><surname>Burton</surname><given-names>FL</given-names></name><name><surname>Cobbe</surname><given-names>SM</given-names></name><name><surname>Smith</surname><given-names>GL</given-names></name></person-group><article-title>The link between repolarisation alternans and ventricular arrhythmia: does the cellular phenomenon extend to the clinical problem?</article-title><source>J Mol Cell Cardiol</source><year>2008</year><volume>45</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2008.03.024</pub-id></citation><citation citation-type="display-unstructured">Myles RC, Burton FL, Cobbe SM, Smith GL (2008) The link between repolarisation alternans and ventricular arrhythmia: does the cellular phenomenon extend to the clinical problem? J Mol Cell Cardiol 45:1&#x02013;10 <pub-id pub-id-type="pmid">18501925</pub-id></citation></ref><ref id="CR35"><label>35.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neyroud</surname><given-names>N</given-names></name><name><surname>Tesson</surname><given-names>F</given-names></name><name><surname>Denjoy</surname><given-names>I</given-names></name><name><surname>Leibovici</surname><given-names>M</given-names></name><name><surname>Donger</surname><given-names>C</given-names></name><name><surname>Barhanin</surname><given-names>J</given-names></name><name><surname>Faure</surname><given-names>S</given-names></name><name><surname>Gary</surname><given-names>F</given-names></name><name><surname>Coumel</surname><given-names>P</given-names></name><name><surname>Petit</surname><given-names>C</given-names></name><name><surname>Schwartz</surname><given-names>K</given-names></name><name><surname>Guicheney</surname><given-names>P</given-names></name></person-group><article-title>A novel mutation in the potassium channel gene <italic>KVLQT1</italic> causes the Jervell and Lange-Nielsen cardioauditory syndrome</article-title><source>Nat Genet</source><year>1997</year><volume>15</volume><fpage>186</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1038/ng0297-186</pub-id></citation><citation citation-type="display-unstructured">Neyroud N, Tesson F, Denjoy I, Leibovici M, Donger C, Barhanin J, Faure S, Gary F, Coumel P, Petit C, Schwartz K, Guicheney P (1997) A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet 15:186&#x02013;189 <pub-id pub-id-type="pmid">9020846</pub-id></citation></ref><ref id="CR36"><label>36.</label><citation citation-type="book"><source>Implantable cardioverter defibrillators for arrhythmias</source><year>2006</year><publisher-loc>London</publisher-loc><publisher-name>NICE</publisher-name></citation><citation citation-type="display-unstructured">National Institute for Health and Clinical Excellence (NICE) (2006) Implantable cardioverter defibrillators for arrhythmias. NICE, London </citation></ref><ref id="CR37"><label>37.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Noble</surname><given-names>D</given-names></name><name><surname>Tsien</surname><given-names>RW</given-names></name></person-group><article-title>Outward membrane currents activated in the plateau range of potentials in cardiac Purkinje fibres</article-title><source>J Physiol</source><year>1969</year><volume>200</volume><fpage>205</fpage><lpage>231</lpage></citation><citation citation-type="display-unstructured">Noble D, Tsien RW (1969) Outward membrane currents activated in the plateau range of potentials in cardiac Purkinje fibres. J Physiol 200:205&#x02013;231 <pub-id pub-id-type="pmid">5761944</pub-id></citation></ref><ref id="CR38"><label>38.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Noble</surname><given-names>D</given-names></name><name><surname>Tsien</surname><given-names>RW</given-names></name></person-group><article-title>Reconstruction of the repolarization process in cardiac Purkinje fibres based on voltage clamp measurements of membrane current</article-title><source>J Physiol</source><year>1969</year><volume>200</volume><fpage>233</fpage><lpage>254</lpage></citation><citation citation-type="display-unstructured">Noble D, Tsien RW (1969) Reconstruction of the repolarization process in cardiac Purkinje fibres based on voltage clamp measurements of membrane current. J Physiol 200:233&#x02013;254 <pub-id pub-id-type="pmid">5761948</pub-id></citation></ref><ref id="CR39"><label>39.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nolasco</surname><given-names>JB</given-names></name><name><surname>Dahlen</surname><given-names>RW</given-names></name></person-group><article-title>A graphic method for the study of alternation in cardiac action potentials</article-title><source>J Appl Physiol</source><year>1968</year><volume>25</volume><fpage>191</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1007/BF00697663</pub-id></citation><citation citation-type="display-unstructured">Nolasco JB, Dahlen RW (1968) A graphic method for the study of alternation in cardiac action potentials. J Appl Physiol 25:191&#x02013;196 <pub-id pub-id-type="pmid">5666097</pub-id></citation></ref><ref id="CR40"><label>40.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pak</surname><given-names>H-N</given-names></name><name><surname>Hong</surname><given-names>SJ</given-names></name><name><surname>Hwang</surname><given-names>GS</given-names></name><name><surname>Lee</surname><given-names>HS</given-names></name><name><surname>Park</surname><given-names>S-W</given-names></name><name><surname>Ahn</surname><given-names>JC</given-names></name><name><surname>Ro</surname><given-names>YM</given-names></name><name><surname>Kim</surname><given-names>Y-H</given-names></name></person-group><article-title>Spatial dispersion of action potential duration restitution kinetics is associated with induction of ventricular tachycardia/fibrillation in humans</article-title><source>J Cardiovasc Electrophysiol</source><year>2004</year><volume>15</volume><fpage>1357</fpage><lpage>1363</lpage><pub-id pub-id-type="doi">10.1046/j.1540-8167.2004.03569.x</pub-id></citation><citation citation-type="display-unstructured">Pak H-N, Hong SJ, Hwang GS, Lee HS, Park S-W, Ahn JC, Ro YM, Kim Y-H (2004) Spatial dispersion of action potential duration restitution kinetics is associated with induction of ventricular tachycardia/fibrillation in humans. J Cardiovasc Electrophysiol 15:1357&#x02013;1363 <pub-id pub-id-type="pmid">15610278</pub-id></citation></ref><ref id="CR41"><label>41.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Papadatos</surname><given-names>GA</given-names></name><name><surname>Wallerstein</surname><given-names>PM</given-names></name><name><surname>Head</surname><given-names>CE</given-names></name><name><surname>Ratcliff</surname><given-names>R</given-names></name><name><surname>Brady</surname><given-names>PA</given-names></name><name><surname>Benndorf</surname><given-names>K</given-names></name><name><surname>Saumarez</surname><given-names>RC</given-names></name><name><surname>Trezise</surname><given-names>AE</given-names></name><name><surname>Huang</surname><given-names>CL</given-names></name><name><surname>Vandenberg</surname><given-names>JI</given-names></name><name><surname>Colledge</surname><given-names>WH</given-names></name><name><surname>Grace</surname><given-names>AA</given-names></name></person-group><article-title>Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene <italic>Scn5a</italic></article-title><source>Proc Natl Acad Sci U S A</source><year>2002</year><volume>99</volume><fpage>6210</fpage><lpage>6215</lpage><pub-id pub-id-type="doi">10.1073/pnas.082121299</pub-id></citation><citation citation-type="display-unstructured">Papadatos GA, Wallerstein PM, Head CE, Ratcliff R, Brady PA, Benndorf K, Saumarez RC, Trezise AE, Huang CL, Vandenberg JI, Colledge WH, Grace AA (2002) Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a. Proc Natl Acad Sci U S A 99:6210&#x02013;6215 <pub-id pub-id-type="pmid">11972032</pub-id></citation></ref><ref id="CR42"><label>42.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>C</given-names></name><name><surname>Antzelevitch</surname><given-names>C</given-names></name></person-group><article-title>Pharmacological approach to the treatment of long and short QT syndromes</article-title><source>Pharmacol Ther</source><year>2008</year><volume>118</volume><fpage>138</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1016/j.pharmthera.2008.02.001</pub-id></citation><citation citation-type="display-unstructured">Patel C, Antzelevitch C (2008) Pharmacological approach to the treatment of long and short QT syndromes. Pharmacol Ther 118:138&#x02013;151 <pub-id pub-id-type="pmid">18378319</pub-id></citation></ref><ref id="CR43"><label>43.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Romano</surname><given-names>C</given-names></name><name><surname>Gemme</surname><given-names>G</given-names></name><name><surname>Pongiglione</surname><given-names>R</given-names></name></person-group><article-title>Aritmie cardiache rare dell&#x02019;eta&#x02019; pediatrica</article-title><source>Clin Pediatr</source><year>1963</year><volume>45</volume><fpage>656</fpage><lpage>683</lpage></citation><citation citation-type="display-unstructured">Romano C, Gemme G, Pongiglione R (1963) Aritmie cardiache rare dell&#x02019;eta&#x02019; pediatrica. Clin Pediatr 45:656&#x02013;683 </citation></ref><ref id="CR44"><label>44.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sabir</surname><given-names>IN</given-names></name><name><surname>Fraser</surname><given-names>JA</given-names></name><name><surname>Killeen</surname><given-names>MJ</given-names></name><name><surname>Grace</surname><given-names>AA</given-names></name><name><surname>Huang</surname><given-names>CL</given-names></name></person-group><article-title>The contribution of refractoriness to arrhythmic substrate in hypokalemic Langendorff-perfused murine hearts</article-title><source>Pfl&#x000fc;gers Archiv</source><year>2007</year><volume>454</volume><fpage>209</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1007/s00424-007-0217-3</pub-id></citation><citation citation-type="display-unstructured">Sabir IN, Fraser JA, Killeen MJ, Grace AA, Huang CL (2007) The contribution of refractoriness to arrhythmic substrate in hypokalemic Langendorff-perfused murine hearts. Pfl&#x000fc;gers Archiv 454:209&#x02013;222 <pub-id pub-id-type="pmid">17295037</pub-id></citation></ref><ref id="CR45"><label>45.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sabir</surname><given-names>IN</given-names></name><name><surname>Li</surname><given-names>LM</given-names></name><name><surname>Grace</surname><given-names>AA</given-names></name><name><surname>Huang</surname><given-names>CL</given-names></name></person-group><article-title>Restitution analysis of alternans and its relationship to arrhythmogenicity in hypokalaemic Langendorff-perfused murine hearts</article-title><source>Pfl&#x000fc;gers Archiv</source><year>2007</year><volume>455</volume><fpage>653</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1007/s00424-007-0327-y</pub-id></citation><citation citation-type="display-unstructured">Sabir IN, Li LM, Grace AA, Huang CL (2007) Restitution analysis of alternans and its relationship to arrhythmogenicity in hypokalaemic Langendorff-perfused murine hearts. Pfl&#x000fc;gers Archiv 455:653&#x02013;666 <pub-id pub-id-type="pmid">17704939</pub-id></citation></ref><ref id="CR46"><label>46.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sabir</surname><given-names>IN</given-names></name><name><surname>Li</surname><given-names>LM</given-names></name><name><surname>Jones</surname><given-names>VJ</given-names></name><name><surname>Goddard</surname><given-names>CA</given-names></name><name><surname>Grace</surname><given-names>AA</given-names></name><name><surname>Huang</surname><given-names>CL</given-names></name></person-group><article-title>Criteria for arrhythmogenicity in genetically-modified Langendorff-perfused murine hearts modelling the congenital long QT syndrome type 3 and the Brugada syndrome</article-title><source>Pfl&#x000fc;gers Archiv</source><year>2007</year><volume>455</volume><issue>4</issue><fpage>637</fpage><lpage>651</lpage><pub-id pub-id-type="doi">10.1007/s00424-007-0326-z</pub-id></citation><citation citation-type="display-unstructured">Sabir IN, Li LM, Jones VJ, Goddard CA, Grace AA, Huang CL (2007) Criteria for arrhythmogenicity in genetically-modified Langendorff-perfused murine hearts modelling the congenital long QT syndrome type 3 and the Brugada syndrome. Pfl&#x000fc;gers Archiv 455(4):637&#x02013;651 <pub-id pub-id-type="pmid">17805561</pub-id></citation></ref><ref id="CR47"><label>47.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salama</surname><given-names>G</given-names></name><name><surname>Baker</surname><given-names>L</given-names></name><name><surname>Wolk</surname><given-names>R</given-names></name><name><surname>Barhanin</surname><given-names>J</given-names></name><name><surname>London</surname><given-names>B</given-names></name></person-group><article-title>Arrhythmia phenotype in mouse models of human long QT</article-title><source>J Interv Card Electrophysiol</source><year>2009</year><volume>24</volume><fpage>77</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1007/s10840-008-9339-6</pub-id></citation><citation citation-type="display-unstructured">Salama G, Baker L, Wolk R, Barhanin J, London B (2009) Arrhythmia phenotype in mouse models of human long QT. J Interv Card Electrophysiol 24:77&#x02013;87 <pub-id pub-id-type="pmid">19148726</pub-id></citation></ref><ref id="CR48"><label>48.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sanguinetti</surname><given-names>M</given-names></name><name><surname>Jiang</surname><given-names>C</given-names></name><name><surname>Curran</surname><given-names>M</given-names></name><name><surname>Keating</surname><given-names>M</given-names></name></person-group><article-title>A mechanistic link between an inherited and an acquired cardiac arrhythmia: <italic>HERG</italic> encodes the I<sub>Kr</sub> potassium channel</article-title><source>Cell</source><year>1995</year><volume>81</volume><fpage>299</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(95)90340-2</pub-id></citation><citation citation-type="display-unstructured">Sanguinetti M, Jiang C, Curran M, Keating M (1995) A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 81:299&#x02013;307 <pub-id pub-id-type="pmid">7736582</pub-id></citation></ref><ref id="CR49"><label>49.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sanguinetti</surname><given-names>MC</given-names></name><name><surname>Curran</surname><given-names>ME</given-names></name><name><surname>Zou</surname><given-names>A</given-names></name><name><surname>Shen</surname><given-names>J</given-names></name><name><surname>Specter</surname><given-names>PS</given-names></name><name><surname>Atkinson</surname><given-names>DL</given-names></name><name><surname>Keating</surname><given-names>MT</given-names></name></person-group><article-title>Coassembly of K<sub>V</sub>LQT1 and minK (IsK) proteins to form cardiac <italic>I</italic><sub>KS</sub> potassium channel</article-title><source>Nature</source><year>1996</year><volume>384</volume><fpage>80</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1038/384080a0</pub-id></citation><citation citation-type="display-unstructured">Sanguinetti MC, Curran ME, Zou A, Shen J, Specter PS, Atkinson DL, Keating MT (1996) Coassembly of KVLQT1 and minK (IsK) proteins to form cardiac IKS potassium channel. Nature 384:80&#x02013;83 <pub-id pub-id-type="pmid">8900283</pub-id></citation></ref><ref id="CR50"><label>50.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Hata</surname><given-names>Y</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name><name><surname>Morita</surname><given-names>H</given-names></name><name><surname>Mizuo</surname><given-names>K</given-names></name><name><surname>Yamanari</surname><given-names>H</given-names></name><name><surname>Saito</surname><given-names>D</given-names></name><name><surname>Ohe</surname><given-names>T</given-names></name></person-group><article-title>Early afterdepolarization abolished by potassium channel opener in a patient with idiopathic long QT syndrome</article-title><source>J Cardiovasc Electrophysiol</source><year>1995</year><volume>6</volume><fpage>279</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1111/j.1540-8167.1995.tb00400.x</pub-id></citation><citation citation-type="display-unstructured">Sato T, Hata Y, Yamamoto M, Morita H, Mizuo K, Yamanari H, Saito D, Ohe T (1995) Early afterdepolarization abolished by potassium channel opener in a patient with idiopathic long QT syndrome. J Cardiovasc Electrophysiol 6:279&#x02013;282 <pub-id pub-id-type="pmid">7647953</pub-id></citation></ref><ref id="CR51"><label>51.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saumarez</surname><given-names>RC</given-names></name><name><surname>Grace</surname><given-names>AA</given-names></name></person-group><article-title>Paced ventricular electrogram fractionation and sudden death in hypertrophic cardiomyopathy and other non-coronary heart diseases</article-title><source>Cardiovasc Res</source><year>2000</year><volume>47</volume><fpage>11</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/S0008-6363(00)00096-1</pub-id></citation><citation citation-type="display-unstructured">Saumarez RC, Grace AA (2000) Paced ventricular electrogram fractionation and sudden death in hypertrophic cardiomyopathy and other non-coronary heart diseases. Cardiovasc Res 47:11&#x02013;22 <pub-id pub-id-type="pmid">10869526</pub-id></citation></ref><ref id="CR52"><label>52.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schram</surname><given-names>G</given-names></name><name><surname>Pourrier</surname><given-names>M</given-names></name><name><surname>Melnyk</surname><given-names>P</given-names></name><name><surname>Nattel</surname><given-names>S</given-names></name></person-group><article-title>Differential distribution of cardiac ion channel expression as a basis for regional specialization in electrical function</article-title><source>Circ Res</source><year>2002</year><volume>90</volume><fpage>939</fpage><lpage>950</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000018627.89528.6F</pub-id></citation><citation citation-type="display-unstructured">Schram G, Pourrier M, Melnyk P, Nattel S (2002) Differential distribution of cardiac ion channel expression as a basis for regional specialization in electrical function. Circ Res 90:939&#x02013;950 <pub-id pub-id-type="pmid">12016259</pub-id></citation></ref><ref id="CR53"><label>53.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schulze-Bahr</surname><given-names>E</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Wedekind</surname><given-names>H</given-names></name><name><surname>Haverkamp</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Ruble</surname><given-names>C</given-names></name><name><surname>Hordt</surname><given-names>M</given-names></name><name><surname>Towbin</surname><given-names>JA</given-names></name><name><surname>Borggrefe</surname><given-names>M</given-names></name><name><surname>Assmann</surname><given-names>G</given-names></name><name><surname>Qu</surname><given-names>X</given-names></name><name><surname>Somberg</surname><given-names>JC</given-names></name><name><surname>Breithardt</surname><given-names>G</given-names></name><name><surname>Oberti</surname><given-names>C</given-names></name><name><surname>Funke</surname><given-names>H</given-names></name></person-group><article-title><italic>KCNE1</italic> mutations cause Jervell and Lange-Nielsen syndrome</article-title><source>Nat Genet</source><year>1997</year><volume>17</volume><fpage>267</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1038/ng1197-267</pub-id></citation><citation citation-type="display-unstructured">Schulze-Bahr E, Wang Q, Wedekind H, Haverkamp W, Chen Q, Sun Y, Ruble C, Hordt M, Towbin JA, Borggrefe M, Assmann G, Qu X, Somberg JC, Breithardt G, Oberti C, Funke H (1997) KCNE1 mutations cause Jervell and Lange-Nielsen syndrome. Nat Genet 17:267&#x02013;268 <pub-id pub-id-type="pmid">9354783</pub-id></citation></ref><ref id="CR54"><label>54.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>PJ</given-names></name><name><surname>Malliani</surname><given-names>A</given-names></name></person-group><article-title>Electrical alternation of the T-wave: clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q-T syndrome</article-title><source>Am Heart J</source><year>1975</year><volume>89</volume><fpage>45</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/0002-8703(75)90008-3</pub-id></citation><citation citation-type="display-unstructured">Schwartz PJ, Malliani A (1975) Electrical alternation of the T-wave: clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q-T syndrome. Am Heart J 89:45&#x02013;50 <pub-id pub-id-type="pmid">1109551</pub-id></citation></ref><ref id="CR55"><label>55.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>PJ</given-names></name><name><surname>Priori</surname><given-names>SG</given-names></name><name><surname>Locati</surname><given-names>EH</given-names></name><name><surname>Napolitano</surname><given-names>C</given-names></name><name><surname>Cantu</surname><given-names>F</given-names></name><name><surname>Towbin</surname><given-names>JA</given-names></name><name><surname>Keating</surname><given-names>MT</given-names></name><name><surname>Hammoude</surname><given-names>H</given-names></name><name><surname>Brown</surname><given-names>AM</given-names></name><name><surname>Chen</surname><given-names>L-SK</given-names></name><name><surname>Colatsky</surname><given-names>TJ</given-names></name></person-group><article-title>Long QT syndrome patients with mutations of the <italic>SCN5A</italic> and <italic>HERG</italic> genes have differential responses to Na<sup>+</sup> channel blockade and to increases in heart rate: implications for gene-specific therapy</article-title><source>Circulation</source><year>1995</year><volume>92</volume><fpage>3381</fpage><lpage>3386</lpage></citation><citation citation-type="display-unstructured">Schwartz PJ, Priori SG, Locati EH, Napolitano C, Cantu F, Towbin JA, Keating MT, Hammoude H, Brown AM, Chen L-SK, Colatsky TJ (1995) Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate: implications for gene-specific therapy. Circulation 92:3381&#x02013;3386 <pub-id pub-id-type="pmid">8521555</pub-id></citation></ref><ref id="CR56"><label>56.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>PJ</given-names></name><name><surname>Spazzolini</surname><given-names>C</given-names></name><name><surname>Crotti</surname><given-names>L</given-names></name><name><surname>Bathen</surname><given-names>J</given-names></name><name><surname>Amlie</surname><given-names>JP</given-names></name><name><surname>Timothy</surname><given-names>K</given-names></name><name><surname>Shkolnikova</surname><given-names>M</given-names></name><name><surname>Berul</surname><given-names>CI</given-names></name><name><surname>Bitner-Glindzicz</surname><given-names>M</given-names></name><name><surname>Toivonen</surname><given-names>L</given-names></name><name><surname>Horie</surname><given-names>M</given-names></name><name><surname>Schulze-Bahr</surname><given-names>E</given-names></name><name><surname>Denjoy</surname><given-names>I</given-names></name></person-group><article-title>The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome</article-title><source>Circulation</source><year>2006</year><volume>113</volume><fpage>783</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.105.592899</pub-id></citation><citation citation-type="display-unstructured">Schwartz PJ, Spazzolini C, Crotti L, Bathen J, Amlie JP, Timothy K, Shkolnikova M, Berul CI, Bitner-Glindzicz M, Toivonen L, Horie M, Schulze-Bahr E, Denjoy I (2006) The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome. Circulation 113:783&#x02013;790 <pub-id pub-id-type="pmid">16461811</pub-id></citation></ref><ref id="CR57"><label>57.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>W</given-names></name><name><surname>Antzelevitch</surname><given-names>C</given-names></name></person-group><article-title>Effects of a K<sup>+</sup> channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the Long-QT syndrome</article-title><source>Circulation</source><year>2000</year><volume>102</volume><fpage>706</fpage><lpage>712</lpage></citation><citation citation-type="display-unstructured">Shimizu W, Antzelevitch C (2000) Effects of a K+ channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the Long-QT syndrome. Circulation 102:706&#x02013;712 <pub-id pub-id-type="pmid">10931813</pub-id></citation></ref><ref id="CR58"><label>58.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>W</given-names></name><name><surname>Kurita</surname><given-names>T</given-names></name><name><surname>Matsuo</surname><given-names>K</given-names></name><name><surname>Suyama</surname><given-names>K</given-names></name><name><surname>Aihara</surname><given-names>N</given-names></name><name><surname>Kamakura</surname><given-names>S</given-names></name><name><surname>Towbin</surname><given-names>JA</given-names></name><name><surname>Shimomura</surname><given-names>K</given-names></name></person-group><article-title>Improvement of repolarization abnormalities by a K<sup>+</sup> channel opener in the LQT1 form of congenital long-QT syndrome</article-title><source>Circulation</source><year>1998</year><volume>97</volume><fpage>1581</fpage><lpage>1588</lpage></citation><citation citation-type="display-unstructured">Shimizu W, Kurita T, Matsuo K, Suyama K, Aihara N, Kamakura S, Towbin JA, Shimomura K (1998) Improvement of repolarization abnormalities by a K+ channel opener in the LQT1 form of congenital long-QT syndrome. Circulation 97:1581&#x02013;1588 <pub-id pub-id-type="pmid">9593563</pub-id></citation></ref><ref id="CR59"><label>59.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>W</given-names></name><name><surname>Yamada</surname><given-names>K</given-names></name><name><surname>Arakaki</surname><given-names>Y</given-names></name><name><surname>Kamiya</surname><given-names>T</given-names></name><name><surname>Shimomura</surname><given-names>K</given-names></name></person-group><article-title>Monophasic action potential recordings during T-wave alternans in congenital long QT syndrome</article-title><source>Am Heart J</source><year>1996</year><volume>132</volume><fpage>699</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.1016/S0002-8703(96)90262-8</pub-id></citation><citation citation-type="display-unstructured">Shimizu W, Yamada K, Arakaki Y, Kamiya T, Shimomura K (1996) Monophasic action potential recordings during T-wave alternans in congenital long QT syndrome. Am Heart J 132:699&#x02013;701 <pub-id pub-id-type="pmid">8800049</pub-id></citation></ref><ref id="CR60"><label>60.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shivkumar</surname><given-names>K</given-names></name><name><surname>Valderrabano</surname><given-names>M</given-names></name></person-group><article-title>Use of potassium channel openers for pharmacologic modulation of cardiac excitability</article-title><source>J Cardiovasc Electrophysiol</source><year>2004</year><volume>15</volume><fpage>821</fpage><lpage>823</lpage><pub-id pub-id-type="doi">10.1046/j.1540-8167.2004.04324.x</pub-id></citation><citation citation-type="display-unstructured">Shivkumar K, Valderrabano M (2004) Use of potassium channel openers for pharmacologic modulation of cardiac excitability. J Cardiovasc Electrophysiol 15:821&#x02013;823 <pub-id pub-id-type="pmid">15250870</pub-id></citation></ref><ref id="CR61"><label>61.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Splawski</surname><given-names>I</given-names></name><name><surname>Timothy</surname><given-names>KW</given-names></name><name><surname>Vincent</surname><given-names>GM</given-names></name><name><surname>Atkinson</surname><given-names>DL</given-names></name><name><surname>Keating</surname><given-names>MT</given-names></name></person-group><article-title>Molecular basis of the long-QT syndrome associated with deafness</article-title><source>N Engl J Med</source><year>1997</year><volume>336</volume><fpage>1562</fpage><lpage>1567</lpage><pub-id pub-id-type="doi">10.1056/NEJM199705293362204</pub-id></citation><citation citation-type="display-unstructured">Splawski I, Timothy KW, Vincent GM, Atkinson DL, Keating MT (1997) Molecular basis of the long-QT syndrome associated with deafness. N Engl J Med 336:1562&#x02013;1567 <pub-id pub-id-type="pmid">9164812</pub-id></citation></ref><ref id="CR62"><label>62.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Splawski</surname><given-names>I</given-names></name><name><surname>Tristani-Firouzi</surname><given-names>M</given-names></name><name><surname>Lehmann</surname><given-names>MH</given-names></name><name><surname>Sanguinetti</surname><given-names>MC</given-names></name><name><surname>Keating</surname><given-names>MT</given-names></name></person-group><article-title>Mutations in the hminK gene cause long QT syndrome and suppress l<sub>Ks</sub> function</article-title><source>Nat Genet</source><year>1997</year><volume>17</volume><fpage>338</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1038/ng1197-338</pub-id></citation><citation citation-type="display-unstructured">Splawski I, Tristani-Firouzi M, Lehmann MH, Sanguinetti MC, Keating MT (1997) Mutations in the hminK gene cause long QT syndrome and suppress lKs function. Nat Genet 17:338&#x02013;340 <pub-id pub-id-type="pmid">9354802</pub-id></citation></ref><ref id="CR63"><label>63.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taggart</surname><given-names>P</given-names></name><name><surname>Sutton</surname><given-names>P</given-names></name><name><surname>Chalabi</surname><given-names>Z</given-names></name><name><surname>Boyett</surname><given-names>MR</given-names></name><name><surname>Simon</surname><given-names>R</given-names></name><name><surname>Elliott</surname><given-names>D</given-names></name><name><surname>Gill</surname><given-names>JS</given-names></name></person-group><article-title>Effect of adrenergic stimulation on action potential duration restitution in humans</article-title><source>Circulation</source><year>2003</year><volume>107</volume><fpage>285</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000044941.13346.74</pub-id></citation><citation citation-type="display-unstructured">Taggart P, Sutton P, Chalabi Z, Boyett MR, Simon R, Elliott D, Gill JS (2003) Effect of adrenergic stimulation on action potential duration restitution in humans. Circulation 107:285&#x02013;289 <pub-id pub-id-type="pmid">12538429</pub-id></citation></ref><ref id="CR64"><label>64.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>G</given-names></name><name><surname>Gurung</surname><given-names>IS</given-names></name><name><surname>Killeen</surname><given-names>MJ</given-names></name><name><surname>Hakim</surname><given-names>P</given-names></name><name><surname>Goddard</surname><given-names>CA</given-names></name><name><surname>Mahaut-Smith</surname><given-names>MP</given-names></name><name><surname>Colledge</surname><given-names>WH</given-names></name><name><surname>Grace</surname><given-names>AA</given-names></name><name><surname>Huang</surname><given-names>CL</given-names></name></person-group><article-title>Effects of L-type Ca<sup>2+</sup> channel antagonism on ventricular arrhythmogenesis in murine hearts containing a modification in the <italic>Scn5a</italic> gene modelling human long QT syndrome 3</article-title><source>J Physiol</source><year>2007</year><volume>578</volume><fpage>85</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2006.121921</pub-id></citation><citation citation-type="display-unstructured">Thomas G, Gurung IS, Killeen MJ, Hakim P, Goddard CA, Mahaut-Smith MP, Colledge WH, Grace AA, Huang CL (2007) Effects of L-type Ca2+ channel antagonism on ventricular arrhythmogenesis in murine hearts containing a modification in the Scn5a gene modelling human long QT syndrome 3. J Physiol 578:85&#x02013;97 <pub-id pub-id-type="pmid">17110414</pub-id></citation></ref><ref id="CR65"><label>65.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>G</given-names></name><name><surname>Killeen</surname><given-names>MJ</given-names></name><name><surname>Grace</surname><given-names>AA</given-names></name><name><surname>Huang</surname><given-names>CLH</given-names></name></person-group><article-title>Pharmacological separation of early afterdepolarizations from arrhythmogenic substrate in &#x02206;KPQ <italic>Scn5a</italic> murine hearts modelling human long QT 3 syndrome</article-title><source>Acta Physiol (Oxf)</source><year>2008</year><volume>192</volume><fpage>505</fpage><lpage>517</lpage><pub-id pub-id-type="doi">10.1111/j.1748-1716.2007.01770.x</pub-id></citation><citation citation-type="display-unstructured">Thomas G, Killeen MJ, Grace AA, Huang CLH (2008) Pharmacological separation of early afterdepolarizations from arrhythmogenic substrate in &#x02206;KPQ Scn5a murine hearts modelling human long QT 3 syndrome. Acta Physiol (Oxf) 192:505&#x02013;517 <pub-id pub-id-type="pmid">17973950</pub-id></citation></ref><ref id="CR66"><label>66.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>G</given-names></name><name><surname>Killeen</surname><given-names>MJ</given-names></name><name><surname>Gurung</surname><given-names>IS</given-names></name><name><surname>Hakim</surname><given-names>P</given-names></name><name><surname>Balasubramaniam</surname><given-names>R</given-names></name><name><surname>Goddard</surname><given-names>CA</given-names></name><name><surname>Grace</surname><given-names>AA</given-names></name><name><surname>Huang</surname><given-names>CL</given-names></name></person-group><article-title>Mechanisms of ventricular arrhythmogenesis in mice following targeted disruption of <italic>KCNE1</italic> modelling long QT syndrome 5</article-title><source>J Physiol</source><year>2007</year><volume>578</volume><fpage>99</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2006.118133</pub-id></citation><citation citation-type="display-unstructured">Thomas G, Killeen MJ, Gurung IS, Hakim P, Balasubramaniam R, Goddard CA, Grace AA, Huang CL (2007) Mechanisms of ventricular arrhythmogenesis in mice following targeted disruption of KCNE1 modelling long QT syndrome 5. J Physiol 578:99&#x02013;114 <pub-id pub-id-type="pmid">17095567</pub-id></citation></ref><ref id="CR67"><label>67.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tyson</surname><given-names>J</given-names></name><name><surname>Tranebjaerg</surname><given-names>L</given-names></name><name><surname>Bellman</surname><given-names>S</given-names></name><name><surname>Wren</surname><given-names>C</given-names></name><name><surname>Taylor</surname><given-names>JF</given-names></name><name><surname>Bathen</surname><given-names>J</given-names></name><name><surname>Aslaksen</surname><given-names>B</given-names></name><name><surname>Sorland</surname><given-names>SJ</given-names></name><name><surname>Lund</surname><given-names>O</given-names></name><name><surname>Malcolm</surname><given-names>S</given-names></name><name><surname>Pembrey</surname><given-names>M</given-names></name><name><surname>Bhattacharya</surname><given-names>S</given-names></name><name><surname>Bitner-Glindzicz</surname><given-names>M</given-names></name></person-group><article-title>IsK and KvLQT1: mutation in either of the two subunits of the slow component of the delayed rectifier potassium channel can cause Jervell and Lange-Nielsen syndrome</article-title><source>Hum Mol Genet</source><year>1997</year><volume>6</volume><fpage>2179</fpage><lpage>2185</lpage><pub-id pub-id-type="doi">10.1093/hmg/6.12.2179</pub-id></citation><citation citation-type="display-unstructured">Tyson J, Tranebjaerg L, Bellman S, Wren C, Taylor JF, Bathen J, Aslaksen B, Sorland SJ, Lund O, Malcolm S, Pembrey M, Bhattacharya S, Bitner-Glindzicz M (1997) IsK and KvLQT1: mutation in either of the two subunits of the slow component of the delayed rectifier potassium channel can cause Jervell and Lange-Nielsen syndrome. Hum Mol Genet 6:2179&#x02013;2185 <pub-id pub-id-type="pmid">9328483</pub-id></citation></ref><ref id="CR68"><label>68.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vetter</surname><given-names>DE</given-names></name><name><surname>Mann</surname><given-names>JR</given-names></name><name><surname>Wangemann</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>McLaughlin</surname><given-names>KJ</given-names></name><name><surname>Lesage</surname><given-names>F</given-names></name><name><surname>Marcus</surname><given-names>DC</given-names></name><name><surname>Lazdunski</surname><given-names>M</given-names></name><name><surname>Heinemann</surname><given-names>SF</given-names></name><name><surname>Barhanin</surname><given-names>J</given-names></name></person-group><article-title>Inner ear defects induced by null mutation of the isk gene</article-title><source>Neuron</source><year>1996</year><volume>17</volume><fpage>1251</fpage><lpage>1264</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(00)80255-X</pub-id></citation><citation citation-type="display-unstructured">Vetter DE, Mann JR, Wangemann P, Liu J, McLaughlin KJ, Lesage F, Marcus DC, Lazdunski M, Heinemann SF, Barhanin J (1996) Inner ear defects induced by null mutation of the isk gene. Neuron 17:1251&#x02013;1264 <pub-id pub-id-type="pmid">8982171</pub-id></citation></ref><ref id="CR69"><label>69.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Joyner</surname><given-names>RW</given-names></name><name><surname>Wagner</surname><given-names>MB</given-names></name><name><surname>Hill</surname><given-names>JA</given-names></name></person-group><article-title>Remodeling of early-phase repolarization: a mechanism of abnormal impulse conduction in heart failure</article-title><source>Circulation</source><year>2006</year><volume>113</volume><fpage>1849</fpage><lpage>1856</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.615682</pub-id></citation><citation citation-type="display-unstructured">Wang Y, Cheng J, Joyner RW, Wagner MB, Hill JA (2006) Remodeling of early-phase repolarization: a mechanism of abnormal impulse conduction in heart failure. Circulation 113:1849&#x02013;1856 <pub-id pub-id-type="pmid">16618832</pub-id></citation></ref><ref id="CR70"><label>70.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Fermini</surname><given-names>B</given-names></name><name><surname>Nattel</surname><given-names>S</given-names></name></person-group><article-title>Sustained depolarization-induced outward current in human atrial myocytes. Evidence for a novel delayed rectifier K<sup>+</sup> current similar to Kv1.5 cloned channel currents</article-title><source>Circ Res</source><year>1993</year><volume>73</volume><fpage>1061</fpage><lpage>1076</lpage></citation><citation citation-type="display-unstructured">Wang Z, Fermini B, Nattel S (1993) Sustained depolarization-induced outward current in human atrial myocytes. Evidence for a novel delayed rectifier K+ current similar to Kv1.5 cloned channel currents. Circ Res 73:1061&#x02013;1076 <pub-id pub-id-type="pmid">8222078</pub-id></citation></ref><ref id="CR71"><label>71.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>OC</given-names></name></person-group><article-title>A new familial cardiac syndrome in children</article-title><source>J Ir Med Assoc</source><year>1964</year><volume>54</volume><fpage>103</fpage><lpage>106</lpage></citation><citation citation-type="display-unstructured">Ward OC (1964) A new familial cardiac syndrome in children. J Ir Med Assoc 54:103&#x02013;106 <pub-id pub-id-type="pmid">14136838</pub-id></citation></ref><ref id="CR72"><label>72.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>JN</given-names></name><name><surname>Chen</surname><given-names>P-S</given-names></name><name><surname>Qu</surname><given-names>Z</given-names></name><name><surname>Karagueuzian</surname><given-names>HS</given-names></name><name><surname>Lin</surname><given-names>S-F</given-names></name><name><surname>Garfinkel</surname><given-names>A</given-names></name></person-group><article-title>Electrical restitution and cardiac fibrillation</article-title><source>J Cardiovasc Electrophysiol</source><year>2002</year><volume>13</volume><fpage>292</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1046/j.1540-8167.2002.00292.x</pub-id></citation><citation citation-type="display-unstructured">Weiss JN, Chen P-S, Qu Z, Karagueuzian HS, Lin S-F, Garfinkel A (2002) Electrical restitution and cardiac fibrillation. J Cardiovasc Electrophysiol 13:292&#x02013;295 <pub-id pub-id-type="pmid">11942602</pub-id></citation></ref><ref id="CR73"><label>73.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>JN</given-names></name><name><surname>Karma</surname><given-names>A</given-names></name><name><surname>Shiferaw</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>P-S</given-names></name><name><surname>Garfinkel</surname><given-names>A</given-names></name><name><surname>Qu</surname><given-names>Z</given-names></name></person-group><article-title>From pulsus to pulseless: the saga of cardiac alternans</article-title><source>Circ Res</source><year>2006</year><volume>98</volume><fpage>1244</fpage><lpage>1253</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000224540.97431.f0</pub-id></citation><citation citation-type="display-unstructured">Weiss JN, Karma A, Shiferaw Y, Chen P-S, Garfinkel A, Qu Z (2006) From pulsus to pulseless: the saga of cardiac alternans. Circ Res 98:1244&#x02013;1253 <pub-id pub-id-type="pmid">16728670</pub-id></citation></ref><ref id="CR74"><label>74.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yanagisawa</surname><given-names>T</given-names></name><name><surname>Taira</surname><given-names>N</given-names></name></person-group><article-title>Effect of 2-nicotinamidethyl nitrate (SG-75) on the membrane potential of left atrial muscle fibres of the dog. Increase in potassium conductance</article-title><source>Naunyn Schmiedebergs Arch Pharmacol</source><year>1980</year><volume>312</volume><fpage>69</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1007/BF00502577</pub-id></citation><citation citation-type="display-unstructured">Yanagisawa T, Taira N (1980) Effect of 2-nicotinamidethyl nitrate (SG-75) on the membrane potential of left atrial muscle fibres of the dog. Increase in potassium conductance. Naunyn Schmiedebergs Arch Pharmacol 312:69&#x02013;76 <pub-id pub-id-type="pmid">6446686</pub-id></citation></ref><ref id="CR75"><label>75.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yanagisawa</surname><given-names>T</given-names></name><name><surname>Taira</surname><given-names>N</given-names></name></person-group><article-title>Effect of 2-nicotinamidethyl nitrate (SG-75) on membrane potentials of canine Purkinje fibers</article-title><source>Jpn J Pharmacol</source><year>1981</year><volume>31</volume><fpage>409</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.1254/jjp.31.409</pub-id></citation><citation citation-type="display-unstructured">Yanagisawa T, Taira N (1981) Effect of 2-nicotinamidethyl nitrate (SG-75) on membrane potentials of canine Purkinje fibers. Jpn J Pharmacol 31:409&#x02013;417 <pub-id pub-id-type="pmid">6458721</pub-id></citation></ref><ref id="CR76"><label>76.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Shi</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>KAI</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name></person-group><article-title>Electrophysiologic effects of nicorandil on the guinea pig long QT1 syndrome model</article-title><source>J Cardiovasc Electrophysiol</source><year>2004</year><volume>15</volume><fpage>815</fpage><lpage>820</lpage><pub-id pub-id-type="doi">10.1046/j.1540-8167.2004.03632.x</pub-id></citation><citation citation-type="display-unstructured">Yang Z, Shi G, Li C, Wang H, Liu KAI, Liu Y (2004) Electrophysiologic effects of nicorandil on the guinea pig long QT1 syndrome model. J Cardiovasc Electrophysiol 15:815&#x02013;820 <pub-id pub-id-type="pmid">15250869</pub-id></citation></ref><ref id="CR77"><label>77.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zipes</surname><given-names>DP</given-names></name><name><surname>Wellens</surname><given-names>HJJ</given-names></name></person-group><article-title>Sudden cardiac death</article-title><source>Circulation</source><year>1998</year><volume>98</volume><fpage>2334</fpage><lpage>2351</lpage></citation><citation citation-type="display-unstructured">Zipes DP, Wellens HJJ (1998) Sudden cardiac death. Circulation 98:2334&#x02013;2351 <pub-id pub-id-type="pmid">9826323</pub-id></citation></ref></ref-list></back></article> 